| Year |
Citation |
Score |
| 2025 |
Oatman SR, Reddy JS, Atashgaran A, Wang X, Min Y, Quicksall Z, Vanelderen F, Carrasquillo MM, Liu CC, Yamazaki Y, Nguyen TT, Heckman M, Zhao N, DeTure M, Murray ME, ... ... Ertekin-Taner N, et al. Integrative Epigenomic Landscape of Alzheimer's Disease Brains Reveals Oligodendrocyte Molecular Perturbations Associated with Tau. Biorxiv : the Preprint Server For Biology. PMID 40027794 DOI: 10.1101/2025.02.12.637140 |
0.442 |
|
| 2025 |
Arnold M, Buyukozkan M, Doraiswamy PM, Nho K, Wu T, Gudnason V, Launer LJ, Wang-Sattler R, Adamski J, De Jager PL, Ertekin-Taner N, Bennett DA, Saykin AJ, Peters A, Suhre K, et al. Individual bioenergetic capacity as a potential source of resilience to Alzheimer's disease. Nature Communications. 16: 1910. PMID 39994231 DOI: 10.1038/s41467-025-57032-0 |
0.354 |
|
| 2025 |
Bhattarai P, Yilmaz E, Cakir EÖ, Korkmaz HY, Lee AJ, Ma Y, Celikkaya H, Cosacak MI, Haage V, Wang X, Nelson N, Lin W, Zhang Y, Nuriel T, Jülich D, ... ... Ertekin-Taner N, et al. ε4-induced Fibronectin at the blood-brain barrier is a conserved pathological mediator of disrupted astrocyte-endothelia interaction in Alzheimer's disease. Biorxiv : the Preprint Server For Biology. PMID 39975303 DOI: 10.1101/2025.01.24.634732 |
0.342 |
|
| 2025 |
Chaudhuri S, Cho M, Stumpff JC, Bice PJ, İş Ö, Ertekin-Taner N, Saykin AJ, Nho K. Cell-specific transcriptional signatures of vascular cells in Alzheimer's disease: perspectives, pathways, and therapeutic directions. Molecular Neurodegeneration. 20: 12. PMID 39876020 DOI: 10.1186/s13024-025-00798-0 |
0.313 |
|
| 2025 |
Liu S, Cho MY, Huang YN, Park T, Chaudhuri S, Rosewood TJ, Bice PJ, Chung D, Bennett DA, Ertekin-Taner N, Saykin AJ, Nho K. Multi-Omics Analysis for Identifying Cell-Type-Specific Druggable Targets in Alzheimer's Disease. Medrxiv : the Preprint Server For Health Sciences. PMID 39830273 DOI: 10.1101/2025.01.08.25320199 |
0.401 |
|
| 2024 |
Yan T, Heckman MG, Craver EC, Liu CC, Rawlinson BD, Wang X, Murray ME, Dickson DW, Ertekin-Taner N, Lou Z, Bu G, Springer W, Fiesel FC. The UFMylation pathway is impaired in Alzheimer's disease. Molecular Neurodegeneration. 19: 97. PMID 39696466 DOI: 10.1186/s13024-024-00784-y |
0.394 |
|
| 2024 |
İş Ö, Min Y, Wang X, Oatman SR, Abraham Daniel A, Ertekin-Taner N. Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer's Disease: A Systematic Review and Future Prospects. Glia. PMID 39652363 DOI: 10.1002/glia.24652 |
0.348 |
|
| 2024 |
Seifar F, Fox EJ, Shantaraman A, Liu Y, Dammer EB, Modeste E, Duong DM, Yin L, Trautwig AN, Guo Q, Xu K, Ping L, Reddy JS, Allen M, Quicksall Z, ... ... Ertekin-Taner N, et al. Large-scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 39535480 DOI: 10.1002/alz.14360 |
0.781 |
|
| 2024 |
Batra R, Krumsiek J, Wang X, Allen M, Blach C, Kastenmüller G, Arnold M, Ertekin-Taner N, Kaddurah-Daouk R. Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 39439201 DOI: 10.1002/alz.14249 |
0.588 |
|
| 2024 |
Nho K, Risacher SL, Apostolova LG, Bice PJ, Brosch JR, Deardorff R, Faber K, Farlow MR, Foroud T, Gao S, Rosewood T, Kim JP, Nudelman K, Yu M, Aisen P, ... ... Ertekin-Taner N, et al. CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET. Nature Communications. 15: 8251. PMID 39304655 DOI: 10.1038/s41467-024-52298-2 |
0.403 |
|
| 2024 |
Tayran H, Yilmaz E, Bhattarai P, Min Y, Wang X, Ma Y, Wang N, Jeong I, Nelson N, Kassara N, Cosacak MI, Dogru RM, Reyes-Dumeyer D, Stenersen JM, Reddy JS, ... ... Ertekin-Taner N, et al. ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer's disease through BDNF/NGFR signaling. Cell Genomics. 100642. PMID 39216475 DOI: 10.1016/j.xgen.2024.100642 |
0.375 |
|
| 2024 |
Reddy JS, Heath L, Linden AV, Allen M, Lopes KP, Seifar F, Wang E, Ma Y, Poehlman WL, Quicksall ZS, Runnels A, Wang Y, Duong DM, Yin L, Xu K, ... ... Ertekin-Taner N, et al. Bridging the gap: Multi-omics profiling of brain tissue in Alzheimer's disease and older controls in multi-ethnic populations. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 39215503 DOI: 10.1002/alz.14208 |
0.737 |
|
| 2024 |
Kuchenbecker LA, Thompson KJ, Hurst CD, Opdenbosch BM, Heckman MG, Reddy JS, Nguyen T, Casellas HL, Sotelo KD, Reddy DJ, Lucas JA, Day GS, Willis FB, Graff-Radford N, Ertekin-Taner N, et al. Nomination of a novel plasma protein biomarker panel capable of classifying Alzheimer's disease dementia with high accuracy in an African American cohort. Biorxiv : the Preprint Server For Biology. PMID 39131392 DOI: 10.1101/2024.07.27.605373 |
0.632 |
|
| 2024 |
Levites Y, Dammer EB, Ran Y, Tsering W, Duong D, Abreha M, Gadhavi J, Lolo K, Trejo-Lopez J, Phillips J, Iturbe A, Erquizi A, Moore BD, Ryu D, Natu A, ... ... Ertekin-Taner N, et al. Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer's disease. Cell Reports. Medicine. 101669. PMID 39127040 DOI: 10.1016/j.xcrm.2024.101669 |
0.532 |
|
| 2024 |
Pottier C, Küçükali F, Baker M, Batzler A, Jenkins GD, van Blitterswijk M, Vicente CT, De Coster W, Wynants S, Van de Walle P, Ross OA, Murray ME, Faura J, Haggarty SJ, van Rooij JG, ... ... Ertekin-Taner N, et al. Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome Sequencing. Medrxiv : the Preprint Server For Health Sciences. PMID 38978643 DOI: 10.1101/2024.06.24.24309088 |
0.325 |
|
| 2024 |
Li W, Petersen RC, Algeciras-Schimnich A, Cogswell PM, Bornhorst JA, Kremers WK, Boeve BF, Jones DT, Botha H, Ramanan VK, Knopman DS, Savica R, Josephs KA, Cliatt-Brown C, Andersen E, ... ... Ertekin-Taner N, et al. Alzheimer Disease Cerebrospinal Fluid Biomarkers in a Tertiary Neurology Practice. Mayo Clinic Proceedings. PMID 38935019 DOI: 10.1016/j.mayocp.2023.12.024 |
0.311 |
|
| 2024 |
Yan T, Heckman MG, Craver EC, Liu CC, Rawlinson BD, Wang X, Murray ME, Dickson DW, Ertekin-Taner N, Lou Z, Bu G, Springer W, Fiesel FC. The UFMylation pathway is impaired in Alzheimer's disease. Biorxiv : the Preprint Server For Biology. PMID 38903110 DOI: 10.1101/2024.05.24.595755 |
0.394 |
|
| 2024 |
İş Ö, Wang X, Reddy JS, Min Y, Yilmaz E, Bhattarai P, Patel T, Bergman J, Quicksall Z, Heckman MG, Tutor-New FQ, Can Demirdogen B, White L, Koga S, Krause V, ... ... Ertekin-Taner N, et al. Gliovascular transcriptional perturbations in Alzheimer's disease reveal molecular mechanisms of blood brain barrier dysfunction. Nature Communications. 15: 4758. PMID 38902234 DOI: 10.1038/s41467-024-48926-6 |
0.826 |
|
| 2024 |
Seifar F, Fox EJ, Shantaraman A, Liu Y, Dammer EB, Modeste E, Duong DM, Yin L, Trautwig AN, Guo Q, Xu K, Ping L, Reddy JS, Allen M, Quicksall Z, ... ... Ertekin-Taner N, et al. Large-scale Deep Proteomic Analysis in Alzheimer's Disease Brain Regions Across Race and Ethnicity. Biorxiv : the Preprint Server For Biology. PMID 38712030 DOI: 10.1101/2024.04.22.590547 |
0.783 |
|
| 2024 |
Reddy JS, Heath L, Linden AV, Allen M, de Paiva Lopes K, Seifar F, Wang E, Ma Y, Poehlman WL, Quicksall ZS, Runnels A, Wang Y, Duong DM, Yin L, Xu K, ... ... Ertekin-Taner N, et al. Bridging the Gap: Multi-Omics Profiling of Brain Tissue in Alzheimer's Disease and Older Controls in Multi-Ethnic Populations. Biorxiv : the Preprint Server For Biology. PMID 38659743 DOI: 10.1101/2024.04.16.589592 |
0.738 |
|
| 2024 |
Kouri N, Frankenhauser I, Peng Z, Labuzan SA, Boon BDC, Moloney CM, Pottier C, Wickland DP, Caetano-Anolles K, Corriveau-Lecavalier N, Tranovich JF, Wood AC, Hinkle KM, Lincoln SJ, Spychalla AJ, ... ... Ertekin-Taner N, et al. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease. Jama Neurology. PMID 38619853 DOI: 10.1001/jamaneurol.2024.0784 |
0.386 |
|
| 2024 |
Bhattarai P, Gunasekaran TI, Belloy ME, Reyes-Dumeyer D, Jülich D, Tayran H, Yilmaz E, Flaherty D, Turgutalp B, Sukumar G, Alba C, McGrath EM, Hupalo DN, Bacikova D, Le Guen Y, ... ... Ertekin-Taner N, et al. Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer's disease. Acta Neuropathologica. 147: 70. PMID 38598053 DOI: 10.1007/s00401-024-02721-1 |
0.462 |
|
| 2024 |
Miller B, Kim SJ, Cao K, Mehta HH, Thumaty N, Kumagai H, Iida T, McGill C, Pike CJ, Nurmakova K, Levine ZA, Sullivan PM, Yen K, Ertekin-Taner N, Atzmon G, et al. Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4-induced brain pathology. Aging Cell. e14153. PMID 38520065 DOI: 10.1111/acel.14153 |
0.378 |
|
| 2024 |
Walton RL, Koga S, Beasley AI, White LJ, Griesacker T, Murray ME, Kasanuki K, Hou X, Fiesel FC, Springer W, Uitti RJ, Fields JA, Botha H, Ramanan VK, Kantarci K, ... ... Ertekin-Taner N, et al. Role of GBA variants in Lewy body disease neuropathology. Acta Neuropathologica. 147: 54. PMID 38472443 DOI: 10.1007/s00401-024-02699-w |
0.372 |
|
| 2024 |
Arnold M, Buyukozkan M, Doraiswamy PM, Nho K, Wu T, Gudnason V, Launer LJ, Wang-Sattler R, Adamski J, De Jager PL, Ertekin-Taner N, Bennett DA, Saykin AJ, Peters A, Suhre K, et al. Individual bioenergetic capacity as a potential source of resilience to Alzheimer's disease. Medrxiv : the Preprint Server For Health Sciences. PMID 38313266 DOI: 10.1101/2024.01.23.23297820 |
0.362 |
|
| 2024 |
Bhattarai P, Gunasekaran TI, Reyes-Dumeyer D, Jülich D, Tayran H, Yilmaz E, Flaherty D, Lantigua R, Medrano M, Rivera D, Recio P, Ertekin-Taner N, Teich AF, Dickson DW, Holley S, et al. Rare genetic variation in Fibronectin 1 ( ) protects against in Alzheimer's disease. Biorxiv : the Preprint Server For Biology. PMID 38260431 DOI: 10.1101/2024.01.02.573895 |
0.443 |
|
| 2024 |
Tayran H, Yilmaz E, Bhattarai P, Min Y, Wang X, Ma Y, Nelson N, Kassara N, Cosacak MI, Dogru RM, Reyes-Dumeyer D, Reddy JS, Qiao M, Flaherty D, Teich AF, ... ... Ertekin-Taner N, et al. ABCA7-dependent Neuropeptide-Y signalling is a resilience mechanism required for synaptic integrity in Alzheimer's disease. Biorxiv : the Preprint Server For Biology. PMID 38260408 DOI: 10.1101/2024.01.02.573893 |
0.428 |
|
| 2024 |
Agra Almeida Quadros AR, Li Z, Wang X, Ndayambaje IS, Aryal S, Ramesh N, Nolan M, Jayakumar R, Han Y, Stillman H, Aguilar C, Wheeler HJ, Connors T, Lopez-Erauskin J, Baughn MW, ... ... Ertekin-Taner N, et al. Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease. Acta Neuropathologica. 147: 9. PMID 38175301 DOI: 10.1007/s00401-023-02655-0 |
0.378 |
|
| 2023 |
Levites Y, Dammer EB, Ran Y, Tsering W, Duong D, Abreha M, Gadhavi J, Lolo K, Trejo-Lopez J, Phillips JL, Iturbe A, Erqiuzi A, Moore BD, Ryu D, Natu A, ... ... Ertekin-Taner N, et al. Aβ Amyloid Scaffolds the Accumulation of Matrisome and Additional Proteins in Alzheimer's Disease. Biorxiv : the Preprint Server For Biology. PMID 38076912 DOI: 10.1101/2023.11.29.568318 |
0.522 |
|
| 2023 |
Min Y, Wang X, İş Ö, Patel TA, Gao J, Reddy JS, Quicksall ZS, Nguyen T, Lin S, Tutor-New FQ, Chalk JL, Mitchell AO, Crook JE, Nelson PT, Van Eldik LJ, ... ... Ertekin-Taner N, et al. Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy. Nature Communications. 14: 6801. PMID 37919278 DOI: 10.1038/s41467-023-42626-3 |
0.712 |
|
| 2023 |
Zhao J, Ikezu TC, Lu W, Macyczko JR, Li Y, Lewis-Tuffin LJ, Martens YA, Ren Y, Zhu Y, Asmann YW, Ertekin-Taner N, Kanekiyo T, Bu G. APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids. Stem Cell Research & Therapy. 14: 214. PMID 37605285 DOI: 10.1186/s13287-023-03444-y |
0.309 |
|
| 2023 |
Ramanan VK, Graff-Radford J, Syrjanen J, Shir D, Algeciras-Schimnich A, Lucas J, Martens YA, Carrasquillo MM, Day GS, Ertekin-Taner N, Lachner C, Willis FB, Knopman DS, Jack CR, Petersen RC, et al. Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort. Neurology. PMID 37580163 DOI: 10.1212/WNL.0000000000207675 |
0.599 |
|
| 2023 |
Catharina Boon BD, Labuzan S, Peng Z, Matchett B, Kouri N, Hinkle KM, Lachner C, Ross O, Ertekin-Taner N, Carter RE, Ferman TJ, Duara R, Dickson DW, Graff-Radford N, Murray ME. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared to Corticolimbic Alzheimer Disease Subtypes. Neurology. PMID 37580158 DOI: 10.1212/WNL.0000000000207685 |
0.402 |
|
| 2023 |
Batra R, Krumsiek J, Wang X, Allen M, Blach C, Kastenmüller G, Arnold M, Ertekin-Taner N, Kaddurah-Daouk RF. Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy. Medrxiv : the Preprint Server For Health Sciences. PMID 37546878 DOI: 10.1101/2023.07.25.23293055 |
0.588 |
|
| 2023 |
Rajabli F, Benchek P, Tosto G, Kushch N, Sha J, Bazemore K, Zhu C, Lee WP, Haut J, Hamilton-Nelson KL, Wheeler NR, Zhao Y, Farrell JJ, Grunin MA, Leung YY, ... ... Ertekin-Taner N, et al. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies and nominates ancestry-specific loci , , and as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. Medrxiv : the Preprint Server For Health Sciences. PMID 37461624 DOI: 10.1101/2023.07.06.23292311 |
0.781 |
|
| 2023 |
Siddiqui T, Cosacak MI, Popova S, Bhattarai P, Yilmaz E, Lee AJ, Min Y, Wang X, Allen M, İş Ö, Atasavum ZT, Rodriguez-Muela N, Vardarajan BN, Flaherty D, Teich AF, ... ... Ertekin-Taner N, et al. Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer's disease. Npj Regenerative Medicine. 8: 33. PMID 37429840 DOI: 10.1038/s41536-023-00311-5 |
0.586 |
|
| 2023 |
Matchett BJ, Lincoln SJ, Baker M, Tamvaka N, Labuzan SA, Hicks Sirmans TN, Moloney CM, Helminger J, Hinkle KM, Cabrera-Rodriguez J, Wickland DP, Johnson PW, Heckman MG, Reddy JS, Younkin SG, ... ... Ertekin-Taner N, et al. The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer's disease: A cross-sectional study. Medicine. 102: e34017. PMID 37327267 DOI: 10.1097/MD.0000000000034017 |
0.75 |
|
| 2023 |
Merchant JP, Zhu K, Henrion MYR, Zaidi SSA, Lau B, Moein S, Alamprese ML, Pearse RV, Bennett DA, Ertekin-Taner N, Young-Pearse TL, Chang R. Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer's disease. Communications Biology. 6: 503. PMID 37188718 DOI: 10.1038/s42003-023-04791-5 |
0.312 |
|
| 2023 |
Caride A, Jang JS, Shi GX, Lenz S, Zhong J, Kim KH, Allen M, Robertson KD, Farrugia G, Ordog T, Ertekin-Taner N, Lee JH. Titration-based normalization of antibody amount improves consistency of ChIP-seq experiments. Bmc Genomics. 24: 171. PMID 37016279 DOI: 10.1186/s12864-023-09253-0 |
0.379 |
|
| 2023 |
Singh NA, Martin PR, Graff-Radford J, Machulda MM, Carrasquillo MM, Ertekin-Taner N, Josephs KA, Whitwell JL. APOE ε4 influences within and between network functional connectivity in posterior cortical atrophy and logopenic progressive aphasia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36999481 DOI: 10.1002/alz.13059 |
0.487 |
|
| 2023 |
Oatman SR, Reddy JS, Quicksall Z, Carrasquillo MM, Wang X, Liu CC, Yamazaki Y, Nguyen TT, Malphrus K, Heckman M, Biswas K, Nho K, Baker M, Martens YA, Zhao N, ... ... Ertekin-Taner N, et al. Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's disease related proteins. Molecular Neurodegeneration. 18: 2. PMID 36609403 DOI: 10.1186/s13024-022-00592-2 |
0.751 |
|
| 2022 |
Ibanez KR, McFarland KN, Phillips J, Allen M, Lessard CB, Zobel L, De La Cruz EG, Shah S, Vo Q, Wang X, Quicksall Z, Ryu D, Funk C, Ertekin-Taner N, Prokop S, et al. Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways. Alzheimer's Research & Therapy. 14: 104. PMID 35897046 DOI: 10.1186/s13195-022-01044-1 |
0.703 |
|
| 2022 |
Batra R, Arnold M, Wörheide MA, Allen M, Wang X, Blach C, Levey AI, Seyfried NT, Ertekin-Taner N, Bennett DA, Kastenmüller G, Kaddurah-Daouk RF, Krumsiek J. The landscape of metabolic brain alterations in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35829654 DOI: 10.1002/alz.12714 |
0.6 |
|
| 2022 |
Singh NA, Tosakulwong N, Graff-Radford J, Machulda MM, Pham NTT, Sintini I, Weigand SD, Schwarz CG, Senjem ML, Carrasquillo MM, Ertekin-Taner N, Jack CR, Lowe VJ, Josephs KA, Whitwell JL. APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35691047 DOI: 10.1002/alz.12711 |
0.674 |
|
| 2022 |
Whitwell J, Martin PR, Graff-Radford J, Machulda M, Sintini I, Buciuc M, Senjem ML, Schwarz CG, Botha H, Carrasquillo MM, Ertekin-Taner N, Lowe VJ, Jack CR, Josephs KA. Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease. Neurology. PMID 35483899 DOI: 10.1212/WNL.0000000000200336 |
0.645 |
|
| 2022 |
Heath L, Earls JC, Magis AT, Kornilov SA, Lovejoy JC, Funk CC, Rappaport N, Logsdon BA, Mangravite LM, Kunkle BW, Martin ER, Naj AC, Ertekin-Taner N, Golde TE, Hood L, et al. Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90. Scientific Reports. 12: 6117. PMID 35413975 DOI: 10.1038/s41598-022-09825-2 |
0.599 |
|
| 2022 |
Patel T, Carnwath TP, Wang X, Allen M, Lincoln SJ, Lewis-Tuffin LJ, Quicksall ZS, Lin S, Tutor-New FQ, Ho CCG, Min Y, Malphrus KG, Nguyen TT, Martin E, Garcia CA, ... ... Ertekin-Taner N, et al. Transcriptional landscape of human microglia implicates age, sex, and APOE-related immunometabolic pathway perturbations. Aging Cell. e13606. PMID 35388616 DOI: 10.1111/acel.13606 |
0.525 |
|
| 2022 |
Reddy JS, Jin J, Lincoln SJ, Ho CCG, Crook JE, Wang X, Malphrus KG, Nguyen T, Tamvaka N, Greig-Custo MT, Lucas JA, Graff-Radford NR, Ertekin-Taner N, Carrasquillo MM. Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans. Ebiomedicine. 103929. PMID 35307406 DOI: 10.1016/j.ebiom.2022.103929 |
0.647 |
|
| 2022 |
Campbell AS, Ho CCG, Atık M, Allen M, Lincoln S, Malphrus K, Nguyen T, Oatman SR, Corda M, Conway O, Strickland S, Petersen RC, Dickson DW, Graff-Radford NR, Ertekin-Taner N. Clinical Deep Phenotyping of Mutation Carriers. Neurology. Genetics. 8: e655. PMID 35047668 DOI: 10.1212/NXG.0000000000000655 |
0.51 |
|
| 2021 |
Ming C, Wang M, Wang Q, Neff R, Wang E, Shen Q, Reddy JS, Wang X, Allen M, Ertekin-Taner N, De Jager PL, Bennett DA, Haroutunian V, Schadt E, Zhang B. Whole genome sequencing-based copy number variations reveal novel pathways and targets in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34918867 DOI: 10.1002/alz.12507 |
0.599 |
|
| 2021 |
Ma Y, Dammer EB, Felsky D, Duong DM, Klein HU, White CC, Zhou M, Logsdon BA, McCabe C, Xu J, Wang M, Wingo TS, Lah JJ, Zhang B, Schneider J, ... ... Ertekin-Taner N, et al. Atlas of RNA editing events affecting protein expression in aged and Alzheimer's disease human brain tissue. Nature Communications. 12: 7035. PMID 34857756 DOI: 10.1038/s41467-021-27204-9 |
0.536 |
|
| 2021 |
Wang X, Allen M, İş Ö, Reddy JS, Tutor-New FQ, Castanedes Casey M, Carrasquillo MM, Oatman SR, Min Y, Asmann YW, Funk C, Nguyen T, Ho CC, Malphrus KG, Seyfried NT, ... ... Ertekin-Taner N, et al. Alzheimer's disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions. The Journal of Clinical Investigation. PMID 34813500 DOI: 10.1172/JCI149904 |
0.82 |
|
| 2021 |
Zhao J, Lu W, Ren Y, Fu Y, Martens YA, Shue F, Davis MD, Wang X, Chen K, Li F, Liu CC, Graff-Radford NR, Wszolek ZK, Younkin SG, Brafman DA, ... Ertekin-Taner N, et al. Correction to: Apolipoprotein E regulates lipid metabolism and α‑synuclein pathology in human iPSC‑derived cerebral organoids. Acta Neuropathologica. PMID 34724591 DOI: 10.1007/s00401-021-02380-6 |
0.395 |
|
| 2021 |
Whitwell JL, Tosakulwong N, Weigand SD, Graff-Radford J, Ertekin-Taner N, Machulda MM, Duffy JR, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Josephs KA. Relationship of APOE, age at onset, amyloid and clinical phenotype in Alzheimer disease. Neurobiology of Aging. 108: 90-98. PMID 34551374 DOI: 10.1016/j.neurobiolaging.2021.08.012 |
0.32 |
|
| 2021 |
Ma Y, Yu L, Olah M, Smith R, Oatman SR, Allen M, Pishva E, Zhang B, Menon V, Ertekin-Taner N, Lunnon K, Bennett DA, Klein HU, De Jager PL. Epigenomic features related to microglia are associated with attenuated effect of APOE ε4 on Alzheimer's disease risk in humans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34482628 DOI: 10.1002/alz.12425 |
0.631 |
|
| 2021 |
Zhao J, Lu W, Ren Y, Fu Y, Martens YA, Shue F, Davis MD, Wang X, Chen K, Li F, Liu CC, Graff-Radford NR, Wszolek ZK, Younkin SG, Brafman DA, ... Ertekin-Taner N, et al. Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids. Acta Neuropathologica. PMID 34453582 DOI: 10.1007/s00401-021-02361-9 |
0.529 |
|
| 2021 |
McFarland KN, Ceballos C, Rosario A, Ladd T, Moore B, Golde G, Wang X, Allen M, Ertekin-Taner N, Funk CC, Robinson M, Baloni P, Rappaport N, Chakrabarty P, Golde TE. Microglia show differential transcriptomic response to Aβ peptide aggregates ex vivo and in vivo. Life Science Alliance. 4. PMID 34127518 DOI: 10.26508/lsa.202101108 |
0.619 |
|
| 2021 |
Reddy JS, Allen M, Ho CCG, Oatman SR, İş Ö, Quicksall ZS, Wang X, Jin J, Patel TA, Carnwath TP, Nguyen TT, Malphrus KG, Lincoln SJ, Carrasquillo MM, Crook JE, ... ... Ertekin-Taner N, et al. Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer's disease. Acta Neuropathologica Communications. 9: 93. PMID 34020725 DOI: 10.1186/s40478-021-01199-2 |
0.759 |
|
| 2021 |
Levites Y, Funk C, Wang X, Chakrabarty P, McFarland KN, Bramblett B, O'Neal V, Liu X, Ladd T, Robinson M, Allen M, Carrasquillo MM, Dickson D, Cruz P, Ryu D, ... ... Ertekin-Taner N, et al. Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy. Molecular Neurodegeneration. 16: 32. PMID 33957936 DOI: 10.1186/s13024-021-00453-4 |
0.735 |
|
| 2021 |
Zhao J, Fu Y, Yamazaki Y, Ren Y, Davis MD, Liu CC, Lu W, Wang X, Chen K, Cherukuri Y, Jia L, Martens YA, Job L, Shue F, Nguyen TT, ... ... Ertekin-Taner N, et al. Author Correction: APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids. Nature Communications. 12: 2707. PMID 33953196 DOI: 10.1038/s41467-021-23081-4 |
0.539 |
|
| 2021 |
Crist AM, Hinkle KM, Wang X, Moloney CM, Matchett BJ, Labuzan SA, Frankenhauser I, Azu NO, Liesinger AM, Lesser ER, Serie DJ, Quicksall ZS, Patel TA, Carnwath TP, DeTure M, ... ... Ertekin-Taner N, et al. Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer's disease. Nature Communications. 12: 2311. PMID 33875655 DOI: 10.1038/s41467-021-22399-3 |
0.751 |
|
| 2021 |
Wickland DP, Ren Y, Sinnwell JP, Reddy JS, Pottier C, Sarangi V, Carrasquillo MM, Ross OA, Younkin SG, Ertekin-Taner N, Rademakers R, Hudson ME, Mainzer LS, Biernacka JM, Asmann YW. Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies. Plos One. 16: e0249305. PMID 33861770 DOI: 10.1371/journal.pone.0249305 |
0.668 |
|
| 2021 |
Feyissa AM, Carrano A, Wang X, Allen M, Ertekin-Taner N, Dickson DW, Jentoft ME, Rosenfeld SS, Tatum WO, Ritaccio AL, Cázares HG, Quiñones-Hinojosa A. Analysis of intraoperative human brain tissue transcriptome reveals putative risk genes and altered molecular pathways in glioma-related seizures. Epilepsy Research. 173: 106618. PMID 33765507 DOI: 10.1016/j.eplepsyres.2021.106618 |
0.456 |
|
| 2021 |
Monti G, Kjolby M, Jensen AMG, Allen M, Reiche J, Møller PL, Comaposada-Baró R, Zolkowski BE, Vieira C, Jørgensen MM, Holm IE, Valdmanis PN, Wellner N, Vægter CB, Lincoln SJ, ... ... Ertekin-Taner N, et al. Expression of an alternatively spliced variant of SORL1 in neuronal dendrites is decreased in patients with Alzheimer's disease. Acta Neuropathologica Communications. 9: 43. PMID 33726851 DOI: 10.1186/s40478-021-01140-7 |
0.595 |
|
| 2021 |
Kouri N, Murray ME, Reddy JS, Serie DJ, Soto-Beasley A, Allen M, Carrasquillo MM, Wang X, Castanedes MC, Baker MC, Rademakers R, Uitti RJ, Graff-Radford NR, Wszolek ZK, Schellenberg GD, ... ... Ertekin-Taner N, et al. Latent trait modeling of tau neuropathology in progressive supranuclear palsy. Acta Neuropathologica. PMID 33635380 DOI: 10.1007/s00401-021-02289-0 |
0.708 |
|
| 2021 |
Li HD, Funk CC, McFarland K, Dammer EB, Allen M, Carrasquillo MM, Levties Y, Chakrabarty P, Burgess JD, Wang X, Dickson D, Seyfried NT, Duong DM, Lah JJ, Younkin SG, ... ... Ertekin-Taner N, et al. Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33480174 DOI: 10.1002/alz.12254 |
0.825 |
|
| 2021 |
Baird DA, Liu JZ, Zheng J, Sieberts SK, Perumal T, Elsworth B, Richardson TG, Chen CY, Carrasquillo MM, Allen M, Reddy JS, De Jager PL, Ertekin-Taner N, Mangravite LM, Logsdon B, et al. Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome. Plos Genetics. 17: e1009224. PMID 33417599 DOI: 10.1371/journal.pgen.1009224 |
0.704 |
|
| 2020 |
Ma Y, Yu L, Olah M, Smith R, Oatman SR, Allen M, Pishva E, Zhang B, Menon V, Ertekin-Taner N, Lunnon K, Bennett DA, Klein HU, De Jager PL. EPIGENOMIC FEATURES RELATED TO MICROGLIA ARE ASSOCIATED WITH ATTENUATED EFFECT OF APOE ε4 ON ALZHEIMER'S DISEASE RISK IN HUMANS. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16. PMID 34393677 DOI: 10.1002/alz.043533 |
0.628 |
|
| 2020 |
Jang JS, Berg B, Holicky E, Eckloff B, Mutawe M, Carrasquillo MM, Ertekin-Taner N, Cuninngham JM. Comparative evaluation for the globin gene depletion methods for mRNA sequencing using the whole blood-derived total RNAs. Bmc Genomics. 21: 890. PMID 33308163 DOI: 10.1186/s12864-020-07304-4 |
0.474 |
|
| 2020 |
Deniz K, Ho CCG, Malphrus KG, Reddy JS, Nguyen T, Carnwath TP, Crook JE, Lucas JA, Graff-Radford NR, Carrasquillo MM, Ertekin-Taner N. Plasma Biomarkers of Alzheimer's Disease in African Americans. Journal of Alzheimer's Disease : Jad. PMID 33252078 DOI: 10.3233/JAD-200828 |
0.828 |
|
| 2020 |
Barker W, Quinonez C, Greig MT, Behar R, Chirinos C, Rodriguez RA, Rosselli M, Rodriguez MJ, Cid RC, Rundek T, McFarland K, Hanson K, Smith G, DeKosky S, Vaillancourt D, ... ... Ertekin-Taner N, et al. Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC). Journal of Alzheimer's Disease : Jad. PMID 33216030 DOI: 10.3233/JAD-200901 |
0.453 |
|
| 2020 |
Mukherjee S, Heath L, Preuss C, Jayadev S, Garden GA, Greenwood AK, Sieberts SK, De Jager PL, Ertekin-Taner N, Carter GW, Mangravite LM, Logsdon BA. Molecular estimation of neurodegeneration pseudotime in older brains. Nature Communications. 11: 5781. PMID 33188183 DOI: 10.1038/s41467-020-19622-y |
0.377 |
|
| 2020 |
Zhao J, Fu Y, Yamazaki Y, Ren Y, Davis MD, Liu CC, Lu W, Wang X, Chen K, Cherukuri Y, Jia L, Martens YA, Job L, Shue F, Nguyen TT, ... ... Ertekin-Taner N, et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids. Nature Communications. 11: 5540. PMID 33139712 DOI: 10.1038/s41467-020-19264-0 |
0.576 |
|
| 2020 |
Strickland SL, Morel H, Prusinski C, Allen M, Patel TA, Carrasquillo MM, Conway OJ, Lincoln SJ, Reddy JS, Nguyen T, Malphrus KG, Soto AI, Walton RL, Crook JE, Murray ME, ... ... Ertekin-Taner N, et al. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy. Acta Neuropathologica Communications. 8: 172. PMID 33092647 DOI: 10.1186/s40478-020-01050-0 |
0.727 |
|
| 2020 |
Hou X, Watzlawik JO, Cook C, Liu CC, Kang SS, Lin WL, DeTure M, Heckman MG, Diehl NN, Al-Shaikh FSH, Walton RL, Ross OA, Melrose HL, Ertekin-Taner N, Bu G, et al. Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33090691 DOI: 10.1002/alz.12198 |
0.73 |
|
| 2020 |
Kunkle BW, Schmidt M, Klein HU, Naj AC, Hamilton-Nelson KL, Larson EB, Evans DA, De Jager PL, Crane PK, Buxbaum JD, Ertekin-Taner N, Barnes LL, Fallin MD, Manly JJ, Go RCP, et al. Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. Jama Neurology. PMID 33074286 DOI: 10.1001/jamaneurol.2020.3536 |
0.573 |
|
| 2020 |
Sieberts SK, Perumal TM, Carrasquillo MM, Allen M, Reddy JS, Hoffman GE, Dang KK, Calley J, Ebert PJ, Eddy J, Wang X, Greenwood AK, Mostafavi S, ... ... Ertekin-Taner N, et al. Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions. Scientific Data. 7: 340. PMID 33046718 DOI: 10.1038/s41597-020-00642-8 |
0.694 |
|
| 2020 |
Wang X, Allen M, Li S, Quicksall ZS, Patel TA, Carnwath TP, Reddy JS, Carrasquillo MM, Lincoln SJ, Nguyen TT, Malphrus KG, Dickson DW, Crook JE, Asmann YW, Ertekin-Taner N. Correction to: Deciphering cellular transcriptional alterations in Alzheimer's disease brains. Molecular Neurodegeneration. 15: 54. PMID 32928256 DOI: 10.1186/S13024-020-00403-6 |
0.731 |
|
| 2020 |
Liu CC, Yamazaki Y, Heckman MG, Martens YA, Jia L, Yamazaki A, Diehl NN, Zhao J, Zhao N, DeTure M, Davis MD, Felton LM, Qiao W, Li Y, Li H, ... ... Ertekin-Taner N, et al. Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32827351 DOI: 10.1002/Alz.12104 |
0.734 |
|
| 2020 |
Funk CC, Casella AM, Jung S, Richards MA, Rodriguez A, Shannon P, Donovan-Maiye R, Heavner B, Chard K, Xiao Y, Glusman G, Ertekin-Taner N, Golde TE, Toga A, Hood L, et al. Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data across 27 Tissue Types. Cell Reports. 32: 108029. PMID 32814038 DOI: 10.1016/J.Celrep.2020.108029 |
0.496 |
|
| 2020 |
Nho K, Nudelman K, Allen M, Hodges A, Kim S, Risacher SL, Apostolova LG, Lin K, Lunnon K, Wang X, Burgess JD, Ertekin-Taner N, Petersen RC, Wang L, Qi Z, et al. Genome-wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer's pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32755048 DOI: 10.1002/Alz.12092 |
0.627 |
|
| 2020 |
Wan YW, Al-Ouran R, Mangleburg CG, Perumal TM, Lee TV, Allison K, Swarup V, Funk CC, Gaiteri C, Allen M, Wang M, Neuner SM, Kaczorowski CC, Philip VM, Howell GR, ... ... Ertekin-Taner N, et al. Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models. Cell Reports. 32: 107908. PMID 32668255 DOI: 10.1016/J.Celrep.2020.107908 |
0.732 |
|
| 2020 |
Wang X, Allen M, Li S, Quicksall ZS, Patel TA, Carnwath TP, Reddy JS, Carrasquillo MM, Lincoln SJ, Nguyen TT, Malphrus KG, Dickson DW, Crook JE, Asmann YW, Ertekin-Taner N. Deciphering cellular transcriptional alterations in Alzheimer's disease brains. Molecular Neurodegeneration. 15: 38. PMID 32660529 DOI: 10.1186/S13024-020-00392-6 |
0.736 |
|
| 2020 |
Yang HS, White CC, Klein HU, Yu L, Gaiteri C, Ma Y, Felsky D, Mostafavi S, Petyuk VA, Sperling RA, Ertekin-Taner N, Schneider JA, Bennett DA, De Jager PL. Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology. Neuron. PMID 32526197 DOI: 10.1016/J.Neuron.2020.05.010 |
0.429 |
|
| 2020 |
Strickland SL, Reddy JS, Allen M, N'songo A, Burgess JD, Corda MM, Ballard T, Wang X, Carrasquillo MM, Biernacka JM, Jenkins GD, Mukherjee S, Boehme K, Crane P, Kauwe JS, ... Ertekin-Taner N, et al. MAPT haplotype-stratified GWAS reveals differential association for AD risk variants. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32400971 DOI: 10.1002/Alz.12099 |
0.778 |
|
| 2020 |
Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, Thambisetty M, Montine TJ, Lee EB, Trojanowski JQ, Beach TG, ... ... Ertekin-Taner N, et al. Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nature Medicine. PMID 32284590 DOI: 10.1038/S41591-020-0815-6 |
0.634 |
|
| 2020 |
Zhao N, Ren Y, Yamazaki Y, Qiao W, Li F, Felton LM, Mahmoudiandehkordi S, Kueider-Paisley A, Sonoustoun B, Arnold M, Shue F, Zheng J, Attrebi ON, Martens YA, Li Z, ... ... Ertekin-Taner N, et al. Alzheimer's Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways. Neuron. PMID 32199103 DOI: 10.1016/J.Neuron.2020.02.034 |
0.455 |
|
| 2020 |
Lloyd GM, Trejo-Lopez JA, Xia Y, McFarland KN, Lincoln SJ, Ertekin-Taner N, Giasson BI, Yachnis AT, Prokop S. Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease. Acta Neuropathologica Communications. 8: 31. PMID 32164763 DOI: 10.1186/S40478-020-0891-3 |
0.46 |
|
| 2020 |
Whitwell JL, Tosakulwong N, Weigand SD, Graff-Radford J, Duffy JR, Clark HM, Machulda MM, Botha H, Utianski RL, Schwarz CG, Senjem ML, Strand EA, Ertekin-Taner N, Jack CR, Lowe VJ, et al. Longitudinal Amyloid-β PET in Atypical Alzheimer's Disease and Frontotemporal Lobar Degeneration. Journal of Alzheimer's Disease : Jad. PMID 32039841 DOI: 10.3233/Jad-190699 |
0.488 |
|
| 2020 |
van der Lee SJ, Conway OJ, Jansen I, Carrasquillo MM, Kleineidam L, van den Akker E, Hernández I, van Eijk KR, Stringa N, Chen JA, Zettergren A, Andlauer TFM, Diez-Fairen M, Simon-Sanchez J, Lleó A, ... ... Ertekin-Taner N, et al. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathologica. PMID 31955222 DOI: 10.1007/s00401-019-02107-8 |
0.731 |
|
| 2019 |
Hanna Al-Shaikh FS, Duara R, Crook JE, Lesser ER, Schaeverbeke J, Hinkle KM, Ross OA, Ertekin-Taner N, Pedraza O, Dickson DW, Graff-Radford NR, Murray ME. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease. Jama Neurology. PMID 31657834 DOI: 10.1001/Jamaneurol.2019.3606 |
0.461 |
|
| 2019 |
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Ertekin-Taner N, et al. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. PMID 31417202 DOI: 10.1038/s41588-019-0495-7 |
0.768 |
|
| 2019 |
Sakae N, Heckman MG, Vargas ER, Carrasquillo MM, Murray ME, Kasanuki K, Ertekin-Taner N, Younkin SG, Dickson DW. Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures. Journal of Alzheimer's Disease : Jad. PMID 31256143 DOI: 10.3233/Jad-190451 |
0.774 |
|
| 2019 |
van der Lee SJ, Conway OJ, Jansen I, Carrasquillo MM, Kleineidam L, van den Akker E, Hernández I, van Eijk KR, Stringa N, Chen JA, Zettergren A, Andlauer TFM, Diez-Fairen M, Simon-Sanchez J, Lleó A, ... ... Ertekin-Taner N, et al. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathologica. PMID 31131421 DOI: 10.1007/S00401-019-02026-8 |
0.765 |
|
| 2019 |
Ebbert MTW, Jensen TD, Jansen-West K, Sens JP, Reddy JS, Ridge PG, Kauwe JSK, Belzil V, Pregent L, Carrasquillo MM, Keene D, Larson E, Crane P, Asmann YW, Ertekin-Taner N, et al. Systematic analysis of dark and camouflaged genes reveals disease-relevant genes hiding in plain sight. Genome Biology. 20: 97. PMID 31104630 DOI: 10.1186/S13059-019-1707-2 |
0.684 |
|
| 2019 |
Duara R, Loewenstein DA, Lizarraga G, Adjouadi M, Barker WW, Greig-Custo MT, Rosselli M, Penate A, Shea YF, Behar R, Ollarves A, Robayo C, Hanson K, Marsiske M, Burke S, ... Ertekin-Taner N, et al. Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity. Neuroimage. Clinical. 22: 101800. PMID 30991618 DOI: 10.1016/J.Nicl.2019.101800 |
0.521 |
|
| 2019 |
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Ertekin-Taner N, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 51: 414-430. PMID 30820047 DOI: 10.1038/s41588-019-0358-2 |
0.791 |
|
| 2019 |
Santos OA, Pedraza O, Lucas JA, Duara R, Greig-Custo MT, Hanna Al-Shaikh FS, Liesinger AM, Bieniek KF, Hinkle KM, Lesser ER, Crook JE, Carrasquillo MM, Ross OA, Ertekin-Taner N, Graff-Radford NR, et al. Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30792090 DOI: 10.1016/J.Jalz.2018.12.013 |
0.684 |
|
| 2019 |
Pottier C, Ren Y, Perkerson RB, Baker M, Jenkins GD, van Blitterswijk M, DeJesus-Hernandez M, van Rooij JGJ, Murray ME, Christopher E, McDonnell SK, Fogarty Z, Batzler A, Tian S, Vicente CT, ... ... Ertekin-Taner N, et al. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD. Acta Neuropathologica. PMID 30739198 DOI: 10.1007/S00401-019-01962-9 |
0.443 |
|
| 2019 |
Whitwell JL, Martin PR, Duffy JR, Clark HM, Machulda MM, Schwarz CG, Weigand SD, Sintini I, Senjem ML, Ertekin-Taner N, Botha H, Utianski RL, Graff-Radford J, Jones DT, Boeve BF, et al. The influence of β-amyloid on [F]AV-1451 in semantic variant of primary progressive aphasia. Neurology. PMID 30635491 DOI: 10.1212/Wnl.0000000000006913 |
0.354 |
|
| 2019 |
Feyissa A, Carrano A, Wang X, Allen M, Ertekin-Taner N, Rosenfeld S, Guerrero-Cazares H, Quinones-Hinojosa A. GENE-48. ANALYSIS OF HUMAN BRAIN TISSUE TRANSCRIPTOME TO IDENTIFY RISK GENES AND ALTERED MOLECULAR PATHWAYS IN GLIOMA-RELATED SEIZURES Neuro-Oncology. 21: vi108-vi108. DOI: 10.1093/Neuonc/Noz175.450 |
0.541 |
|
| 2019 |
Allen M, Reddy JS, Carrasquillo MM, Wang X, Lincoln SJ, Nguyen T, Malphrus KG, Asmann YW, Murray ME, Bu G, Dickson DW, Ertekin-Taner N. INTEGRATIVE GENOMIC PROFILING TO IDENTIFY GENES AND PATHWAYS ASSOCIATED WITH VASCULAR RISK IN AD Alzheimer's & Dementia. 15: P1617. DOI: 10.1016/J.Jalz.2019.06.4843 |
0.723 |
|
| 2019 |
Patel T, Carnwath T, Lewis-Tuffin L, Allen M, Lincoln SJ, Wang X, Deniz K, Is O, Martin E, Garcia CA, Louie C, ReFaey K, Duran IS, Cazares HG, Wharen R, ... ... Ertekin-Taner N, et al. O4-10-01: CHARACTERIZING CELL TYPE-SPECIFIC EXPRESSION SIGNATURES IN BRAIN USING SINGLE CELL RNA SEQUENCING Alzheimer's & Dementia. 15: P1258-P1258. DOI: 10.1016/J.Jalz.2019.06.4794 |
0.767 |
|
| 2019 |
Reddy JS, Allen M, Wang X, Biernacka JM, Gregory JD, Carrasquillo MM, Ertekin-Taner N, Younkin SG. O2-10-01: STOP-GAIN AND NON-SYNONYMOUS VARIANTS IN NOVEL GENES OF AN IMMUNE CO-REGULATORY NETWORK SHOW STRONG ASSOCIATION WITH ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P563-P564. DOI: 10.1016/J.Jalz.2019.06.4505 |
0.776 |
|
| 2019 |
Whitwell JL, Tosakulwong N, Weigand SD, Graff-Radford J, Duffy JR, Clark HM, Machulda MM, Botha H, Utianski RL, Schwarz CG, Senjem ML, Strand EA, Ertekin-Taner N, Jack CR, Lowe VJ, et al. P4-330: LONGITUDINAL BEHAVIOR OF BETA-AMYLOID IN NEURODEGENERATIVE DEMENTIAS Alzheimer's & Dementia. 15: P1422-P1422. DOI: 10.1016/J.Jalz.2019.06.4000 |
0.331 |
|
| 2019 |
Funk CC, Shannon P, Gibbs D, Rappaport N, Allen M, Carrasquillo MM, Ertekin-Taner N, Golde TE, Shmulevich I, Hood L, Price ND. P4-103: CELL-TYPE SPECIFIC MECHANISTIC AND DIRECTIONAL TRANSCRIPTIONAL REGULATORY NETWORKS IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P1314-P1315. DOI: 10.1016/J.Jalz.2019.06.3764 |
0.719 |
|
| 2019 |
Duara R, Loewenstein DA, Lizarraga G, Adjouadi M, Barker WW, Greig-Custo MT, Rosselli M, Curiel RE, Hanson K, Marsiske M, Ertekin-Taner N, Vaillancourt D, DeKosky S, de Santi S, Golde TE. P2-427: THE RELATIONSHIP BETWEEN HISPANIC ETHNICITY, AMYLOID LOAD AND APOE4 CARRIER STATUS Alzheimer's & Dementia. 15: P775-P776. DOI: 10.1016/J.Jalz.2019.06.2834 |
0.532 |
|
| 2019 |
Stephens A, Allen M, Atik M, Lincoln SJ, Malphrus KG, Nguyen T, Corda MM, Conway OJ, Graff-Radford NR, Dickson DW, Ertekin-Taner N. P2-294: RETROSPECTIVE REVIEW OF CLINICAL FEATURES OF ABCA7
LOSS-OF-FUNCTION MUTATION CARRIERS IN LATE-ONSET ALZHEIMER'S DISEASE Alzheimer's & Dementia. 15: P699-P699. DOI: 10.1016/J.Jalz.2019.06.2701 |
0.592 |
|
| 2018 |
Conway OJ, Carrasquillo MM, Wang X, Bredenberg JM, Reddy JS, Strickland SL, Younkin CS, Burgess JD, Allen M, Lincoln SJ, Nguyen T, Malphrus KG, Soto AI, Walton RL, Boeve BF, ... ... Ertekin-Taner N, et al. ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans. Molecular Neurodegeneration. 13: 53. PMID 30326945 DOI: 10.1186/S13024-018-0289-X |
0.752 |
|
| 2018 |
Goldstein ED, Ertekin-Taner N, Stephens A, Carrasquillo MM, Boeve B, Tatum WO, Feyissa AM. Electroencephalogram findings in patients with posterior cortical atrophy. Neurologia I Neurochirurgia Polska. PMID 30297099 DOI: 10.1016/J.Pjnns.2018.09.008 |
0.637 |
|
| 2018 |
Liesinger AM, Graff-Radford NR, Duara R, Carter RE, Hanna Al-Shaikh FS, Koga S, Hinkle KM, DiLello SK, Johnson MF, Aziz A, Ertekin-Taner N, Ross OA, Dickson DW, Murray ME. Sex and age interact to determine clinicopathologic differences in Alzheimer's disease. Acta Neuropathologica. PMID 30219939 DOI: 10.1007/S00401-018-1908-X |
0.366 |
|
| 2018 |
Gusareva ES, Twizere JC, Sleegers K, Dourlen P, Abisambra JF, Meier S, Cloyd R, Weiss B, Dermaut B, Bessonov K, van der Lee SJ, Carrasquillo MM, Katsumata Y, Cherkaoui M, Asselbergh B, ... ... Ertekin-Taner N, et al. Male-specific epistasis between WWC1 and TLN2 genes is associated with Alzheimer's disease. Neurobiology of Aging. PMID 30201328 DOI: 10.1016/J.Neurobiolaging.2018.08.001 |
0.666 |
|
| 2018 |
Chakrabarty P, Li A, Ladd TB, Strickland MR, Koller EJ, Burgess JD, Funk CC, Cruz PE, Allen M, Yaroshenko M, Wang X, Younkin C, Reddy J, Lohrer B, Mehrke L, ... ... Ertekin-Taner N, et al. TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's disease. The Journal of Experimental Medicine. PMID 30158114 DOI: 10.1084/Jem.20180484 |
0.756 |
|
| 2018 |
Dickson DW, Heckman MG, Murray ME, Soto AI, Walton RL, Diehl NN, van Gerpen JA, Uitti RJ, Wszolek ZK, Ertekin-Taner N, Knopman DS, Petersen RC, Graff-Radford NR, Boeve BF, Bu G, et al. ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology. PMID 30143564 DOI: 10.1212/Wnl.0000000000006212 |
0.469 |
|
| 2018 |
Allen M, Wang X, Serie DJ, Strickland SL, Burgess JD, Koga S, Younkin CS, Nguyen TT, Malphrus KG, Lincoln SJ, Alamprese M, Zhu K, Chang R, Carrasquillo MM, Kouri N, ... ... Ertekin-Taner N, et al. Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy. Acta Neuropathologica. PMID 30136084 DOI: 10.1007/S00401-018-1900-5 |
0.805 |
|
| 2018 |
Blechingberg J, Poulsen ASA, Kjølby M, Monti G, Allen M, Ivarsen AK, Lincoln SJ, Thotakura G, Vægter CB, Ertekin-Taner N, Nykjær A, Andersen OM. An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor. Neurobiology of Aging. PMID 30078640 DOI: 10.1016/J.Neurobiolaging.2018.06.021 |
0.616 |
|
| 2018 |
Ren Y, van Blitterswijk M, Allen M, Carrasquillo MM, Reddy JS, Wang X, Beach TG, Dickson DW, Ertekin-Taner N, Asmann YW, Rademakers R. TMEM106B haplotypes have distinct gene expression patterns in aged brain. Molecular Neurodegeneration. 13: 35. PMID 29970152 DOI: 10.1186/S13024-018-0268-2 |
0.741 |
|
| 2018 |
Pottier C, Zhou X, Perkerson RB, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, ... ... Ertekin-Taner N, et al. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. The Lancet. Neurology. PMID 29724592 DOI: 10.1016/S1474-4422(18)30126-1 |
0.378 |
|
| 2018 |
Ren Y, Reddy JS, Pottier C, Sarangi V, Tian S, Sinnwell JP, McDonnell SK, Biernacka JM, Carrasquillo MM, Ross OA, Ertekin-Taner N, Rademakers R, Hudson M, Mainzer LS, Asmann YW. Identification of missing variants by combining multiple analytic pipelines. Bmc Bioinformatics. 19: 139. PMID 29661148 DOI: 10.1186/S12859-018-2151-0 |
0.607 |
|
| 2018 |
Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda M, Senjem ML, Spychalla AJ, Vemuri P, Jones DT, Drubach DA, Knopman DS, Boeve BF, Ertekin-Taner N, Petersen RC, Lowe VJ, et al. Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29605222 DOI: 10.1016/J.Jalz.2018.02.020 |
0.479 |
|
| 2018 |
Chung J, Zhang X, Allen M, Wang X, Ma Y, Beecham G, Montine TJ, Younkin SG, Dickson DW, Golde TE, Price ND, Ertekin-Taner N, Lunetta KL, Mez J, et al. Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer's disease. Alzheimer's Research & Therapy. 10: 22. PMID 29458411 DOI: 10.1186/S13195-018-0349-Z |
0.785 |
|
| 2018 |
Razquin C, Ortega-Cubero S, Rojo-Bustamante E, Diez-Fairen M, Lorenzo E, Alonso E, Ezquerra M, Ross OA, Carcel M, Lorenzo-Betancor O, Soto AI, Burgess JD, Ertekin-Taner N, Dickson DW, Pastor MA, et al. Target-enriched sequencing of chromosome 17q21.31 in sporadic tauopathies reveals no candidate variants. Neurobiology of Aging. PMID 29398119 DOI: 10.1016/J.Neurobiolaging.2017.12.026 |
0.403 |
|
| 2018 |
Ridge PG, Karch CM, Hsu S, Arano I, Teerlink CC, Ebbert MTW, Murcia JDG, Farnham JM, Damato AR, Allen M, Wang X, Harari O, Fernandez VM, Guerreiro R, Bras J, ... ... Ertekin-Taner N, et al. Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience. Genome Medicine. 10: 4. PMID 29329552 DOI: 10.1186/S13073-018-0516-7 |
0.775 |
|
| 2018 |
Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda M, Senjem ML, Schwarz CG, Spychalla AJ, Jones DT, Drubach DA, Knopman DS, Boeve BF, Ertekin-Taner N, Petersen RC, Lowe VJ, et al. [18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease. Annals of Neurology. PMID 29323751 DOI: 10.1002/Ana.25142 |
0.309 |
|
| 2018 |
Monti G, Kjølby MF, Barò RC, Wellner N, Reiche J, Lincoln SJ, Allen M, Ertekin-Taner N, Melnikova M, Holm IE, Vaegter CB, Nyegaard M, Nykjaer A, Andersen OM. P4-259: A Novel Sorl1 Transcript That Is Downregulated In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.07.081 |
0.655 |
|
| 2018 |
Strickland SL, Reddy JS, Allen M, N'Songo A, Burgess JD, Corda MM, Ballard T, Mukherjee S, Boehme KL, Crane PK, Kauwe J, Ertekin-Taner N, Adgc. P2-141: Chr17Q21 H2 Haplotype Stratified Gwas Reveals Differential Association For Ad Risk Variants Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.827 |
0.621 |
|
| 2017 |
Ridge PG, Karch CM, Hsu S, Arano I, Teerlink CC, Ebbert MTW, Gonzalez Murcia JD, Farnham JM, Damato AR, Allen M, Wang X, Harari O, Fernandez VM, Guerreiro R, Bras J, ... ... Ertekin-Taner N, et al. Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience. Genome Medicine. 9: 100. PMID 29183403 DOI: 10.1186/S13073-017-0486-1 |
0.778 |
|
| 2017 |
Allen M, Wang X, Burgess JD, Watzlawik J, Serie DJ, Younkin CS, Nguyen T, Malphrus KG, Lincoln S, Carrasquillo MM, Ho C, Chakrabarty P, Strickland S, Murray ME, Swarup V, ... ... Ertekin-Taner N, et al. Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29107053 DOI: 10.1016/J.Jalz.2017.09.012 |
0.845 |
|
| 2017 |
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Ertekin-Taner N, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916 |
0.832 |
|
| 2017 |
Ertekin-Taner N. Identifying therapeutic targets for Alzheimer's disease with big data. Neurodegenerative Disease Management. 7: 101-105. PMID 28540771 DOI: 10.2217/Nmt-2017-0008 |
0.478 |
|
| 2017 |
N'Songo A, Carrasquillo MM, Wang X, Burgess JD, Nguyen T, Asmann YW, Serie DJ, Younkin SG, Allen M, Pedraza O, Duara R, Greig Custo MT, Graff-Radford NR, Ertekin-Taner N. African American exome sequencing identifies potential risk variants at Alzheimer disease loci. Neurology. Genetics. 3: e141. PMID 28480329 DOI: 10.1212/Nxg.0000000000000141 |
0.811 |
|
| 2017 |
Mukherjee S, Russell JC, Carr DT, Burgess JD, Younkin MA, Serie D, Boehme KL, Kauwe JS, Naj AC, Fardo DW, Dickson DW, Montine TJ, Ertekin-Taner N, Kaeberlein MR, Crane PK. Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28242297 DOI: 10.1016/J.Jalz.2017.01.016 |
0.517 |
|
| 2017 |
Jun GR, Chung J, Mez J, Barber R, Beecham GW, Bennett DA, Buxbaum JD, Byrd GS, Carrasquillo MM, Crane PK, Cruchaga C, De Jager P, Ertekin-Taner N, Evans D, Fallin MD, et al. Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28183528 DOI: 10.1016/J.Jalz.2016.12.012 |
0.76 |
|
| 2017 |
N'Songo A, Carrasquillo MM, Wang X, Nguyen T, Asmann Y, Younkin SG, Allen M, Duara R, Custo MT, Graff-Radford N, Ertekin-Taner N. Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants. Journal of Alzheimer's Disease : Jad. PMID 28106563 DOI: 10.3233/Jad-161185 |
0.8 |
|
| 2017 |
Allen M, Lincoln SJ, Corda M, Watzlawik JO, Carrasquillo MM, Reddy JS, Burgess JD, Nguyen T, Malphrus K, Petersen RC, Graff-Radford NR, Dickson DW, Ertekin-Taner N. ABCA7 loss-of-function variants, expression, and neurologic disease risk. Neurology. Genetics. 3: e126. PMID 28097223 DOI: 10.1212/Nxg.0000000000000126 |
0.834 |
|
| 2017 |
Allen M, Wang X, Reddy JS, Carrasquillo MM, Younkin CS, Funk C, Burgess JD, Nguyen T, Lincoln SJ, Malphrus KG, Asmann YW, Younkin SG, Price ND, Golde TE, Dickson DW, ... Ertekin-Taner N, et al. USING TISSUE-BASED TRANSCRIPTOMICS TO PROFILE CELL TYPE VARIABILITY IN THE BRAIN Alzheimer's & Dementia. 13: P588-P589. DOI: 10.1016/J.Jalz.2017.07.218 |
0.697 |
|
| 2017 |
Allen M, Wang X, Younkin CS, Serie D, Burgess JD, Nguyen T, Lincoln SJ, Malphrus KG, Carrasquillo MM, Kouri N, Murray ME, Schellenberg GD, Younkin SG, Crook JE, Asmann YW, ... ... Ertekin-Taner N, et al. [P4-074]: INTEGRATIVE SYSTEMS BIOLOGY APPROACH TO IDENTIFY NOVEL RISK FACTORS FOR PSP Alzheimer's & Dementia. 13: P1286-P1286. DOI: 10.1016/J.Jalz.2017.06.1939 |
0.712 |
|
| 2017 |
Varatharajah Y, Younkin M, Wang X, Athreya A, Messaoud S, Iyer R, Ertekin-Taner N. [P3–117]: UNSUPERVISED ANALYSIS OF TRANSCRIPTOMIC DATA FOR DEMYSTIFYING THE CAUSE OF ALZHEIMER's DISEASE Alzheimers & Dementia. 13: 979. DOI: 10.1016/J.Jalz.2017.06.1328 |
0.482 |
|
| 2017 |
Carrasquillo MM, Ho CC, Nsongo A, Wang X, Burgess JD, Nguyen T, Ma L, Bisceglio GD, Lincoln SJ, Malphrus KG, Asmann YW, Younkin SG, Duara R, Greig Custo MT, Graff-Radford NR, ... Ertekin-Taner N, et al. [P3-096]: NOVEL CANDIDATE AD-RISK LOCI IDENTIFIED THROUGH WHOLE EXOME SEQUENCING IN AFRICAN-AMERICANS Alzheimer's & Dementia. 13: P971-P971. DOI: 10.1016/J.Jalz.2017.06.1306 |
0.714 |
|
| 2016 |
Gusareva ES, Carrasquillo MM, Bellenguez C, Cuyvers E, Colon S, Graff-Radford NR, Petersen RC, Dickson DW, Mahachie John JM, Bessonov K, Van Broeckhoven C, Ramirez A, Harold D, Williams J, ... ... Ertekin-Taner N, et al. Corrigendum to "Genome-wide association interaction analysis for Alzheimer's disease." [Neurobiol. Aging 35 (2014) 2436-2443]. Neurobiology of Aging. 37: 211. PMID 28757004 DOI: 10.1016/J.Neurobiolaging.2015.11.015 |
0.664 |
|
| 2016 |
Carrasquillo MM, Allen M, Burgess JD, Wang X, Strickland SL, Aryal S, Siuda J, Kachadoorian ML, Medway C, Younkin CS, Nair A, Wang C, Chanana P, Serie D, Nguyen T, ... ... Ertekin-Taner N, et al. A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27939925 DOI: 10.1016/J.Jalz.2016.10.005 |
0.826 |
|
| 2016 |
Ma L, Allen M, Sakae N, Ertekin-Taner N, Graff-Radford NR, Dickson DW, Younkin SG, Sevlever D. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains. Molecular Neurodegeneration. 11: 72. PMID 27887626 DOI: 10.1186/S13024-016-0137-9 |
0.734 |
|
| 2016 |
Mez J, Chung J, Jun G, Kriegel J, Bourlas AP, Sherva R, Logue MW, Barnes LL, Bennett DA, Buxbaum JD, Byrd GS, Crane PK, Ertekin-Taner N, Evans D, Fallin MD, et al. Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27770636 DOI: 10.1016/J.Jalz.2016.09.002 |
0.474 |
|
| 2016 |
Allen M, Carrasquillo MM, Funk C, Heavner BD, Zou F, Younkin CS, Burgess JD, Chai HS, Crook J, Eddy JA, Li H, Logsdon B, Peters MA, Dang KK, Wang X, ... ... Ertekin-Taner N, et al. Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases. Scientific Data. 3: 160089. PMID 27727239 DOI: 10.1038/Sdata.2016.89 |
0.845 |
|
| 2016 |
Pottier C, Ravenscroft TA, Brown PH, Finch NA, Baker M, Parsons M, Asmann YW, Ren Y, Christopher E, Levitch D, van Blitterswijk M, Cruchaga C, Campion D, Nicolas G, Richard AC, ... ... Ertekin-Taner N, et al. TYROBP genetic variants in early-onset Alzheimer's disease. Neurobiology of Aging. PMID 27658901 DOI: 10.1016/J.Neurobiolaging.2016.07.028 |
0.673 |
|
| 2016 |
Heckman MG, Soto-Ortolaza AI, Sanchez Contreras MY, Murray ME, Pedraza O, Diehl NN, Walton R, Labbé C, Lorenzo-Betancor O, Uitti RJ, van Gerpen J, Ertekin-Taner N, Smith GE, Kantarci K, Savica R, et al. LRRK2 variation and dementia with Lewy bodies. Parkinsonism & Related Disorders. PMID 27521182 DOI: 10.1016/J.Parkreldis.2016.07.015 |
0.378 |
|
| 2016 |
Hodges K, Brewer SS, Labbé C, Soto-Ortolaza AI, Walton RL, Strongosky AJ, Uitti RJ, van Gerpen JA, Ertekin-Taner N, Kantarci K, Lowe VJ, Parisi JE, Savica R, Graff-Radford J, Jones DT, et al. RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies. Neurobiology of Aging. 45: 107-108. PMID 27459931 DOI: 10.1016/J.Neurobiolaging.2016.03.021 |
0.342 |
|
| 2016 |
Walton RL, Soto-Ortolaza AI, Murray ME, Lorenzo-Betancor O, Ogaki K, Heckman MG, Rayaprolu S, Rademakers R, Ertekin-Taner N, Uitti RJ, van Gerpen JA, Wszolek ZK, Smith GE, Kantarci K, Lowe VJ, et al. TREM2 p.R47H substitution is not associated with dementia with Lewy bodies. Neurology. Genetics. 2: e85. PMID 27458607 DOI: 10.1212/Nxg.0000000000000085 |
0.472 |
|
| 2016 |
Labbé C, Heckman MG, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Murray ME, Allen M, Uitti RJ, Wszolek ZK, Smith GE, Kantarci K, Knopman DS, Lowe VJ, Jack CR, Ertekin-Taner N, et al. MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27287057 DOI: 10.1016/J.Jalz.2016.05.002 |
0.604 |
|
| 2016 |
Allen M, Burgess JD, Ballard T, Serie D, Wang X, Younkin CS, Sun Z, Kouri N, Baheti S, Wang C, Carrasquillo MM, Nguyen T, Lincoln S, Malphrus K, Murray M, ... ... Ertekin-Taner N, et al. Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci. Acta Neuropathologica. PMID 27115769 DOI: 10.1007/S00401-016-1576-7 |
0.791 |
|
| 2016 |
Schott JM, Crutch SJ, Carrasquillo MM, Uphill J, Shakespeare TJ, Ryan NS, Yong KX, Lehmann M, Ertekin-Taner N, Graff-Radford NR, Boeve BF, Murray ME, Khan QU, Petersen RC, Dickson DW, et al. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26993346 DOI: 10.1016/J.Jalz.2016.01.010 |
0.697 |
|
| 2016 |
Allen M, Wang X, Burgess JD, Nguyen T, Malphrus KG, Nho K, Serie D, Strickland SL, Lincoln S, Carrasquillo MM, Crook JE, Schellenberg GD, Knopman DS, Saykin AJ, Lowe VJ, ... ... Ertekin-Taner N, et al. Blood Gene Expression Changes Implicated In Alzheimer’S Disease Alzheimers & Dementia. 12: 448. DOI: 10.1016/J.Jalz.2016.06.865 |
0.742 |
|
| 2016 |
Ertekin-Taner N. Accelerating Medicines Partnership: Identifying Therapeutic Targets For Alzheimer’S Disease With Comparative Transcriptomics Alzheimers & Dementia. 12: 322. DOI: 10.1016/J.Jalz.2016.06.587 |
0.355 |
|
| 2016 |
Golde TE, Ertekin-Taner N, Chakrabarty P, Allen M, Carrasquillo MM, Dickson DW, Younkin SG, Levites Y, Price ND, Funk C, Heavner BD, Logsdon B, Mangravite LM, Li H, Burgess JD, et al. F2-01-04: From Systems Level Transcriptomics to new Immune Targets for Alzheimer’s Disease Alzheimer's & Dementia. 12: P215-P216. DOI: 10.1016/J.Jalz.2016.06.383 |
0.744 |
|
| 2016 |
Allen M, Wang X, Younkin CS, Serie D, Sun Z, Burgess JD, Baheti S, Kouri N, Nguyen T, Lincoln S, Malphrus KG, Carrasquillo MM, Zou F, Chai H, Murray ME, ... ... Ertekin-Taner N, et al. P4-048: Convergent Analysis of Endophenotypes in Progressive Supranuclear Palsy Alzheimer's & Dementia. 12: P1032-P1033. DOI: 10.1016/J.Jalz.2016.06.2137 |
0.716 |
|
| 2016 |
Logsdon BA, Zhang B, Komashko V, Mostafavi S, Chen M, Perumal TM, Funk C, Allen M, Amberkar S, Hide W, Friend SH, Bennett DA, Schadt E, de Jager P, Price ND, ... Ertekin-Taner N, et al. P4-031: Integrative Network Analysis of Multiple Alzheimer's Disease Rnaseq Studies From the Accelerating Medicine Partnership-Alzheimer's Disease Consortium Alzheimer's & Dementia. 12: P1026-P1027. DOI: 10.1016/J.Jalz.2016.06.2120 |
0.656 |
|
| 2016 |
Dang K, Perumal TM, Allen M, Funk C, Wang M, Xu J, Logsdon B, Yu L, Schuyler S, Friend SH, Bennett DA, Zhang B, Schadt E, de Jager P, Price ND, ... Ertekin-Taner N, et al. P4-027: Combing Evidence Across Multiple Cohorts for Systems-Based Target Discovery: the AMP-AD Knowledge Portal Alzheimer's & Dementia. 12: P1025-P1025. DOI: 10.1016/J.Jalz.2016.06.2116 |
0.551 |
|
| 2016 |
Clement NS, Medway C, Ertekin-Taner N, Carrasquillo MM, Younkin SG, Guetta-Baranes T, Burgess JD, Allen M, Tam T, Dickson DW, Petersen RC, Graff-Radford NR, Chappell S, Morgan K. P3-092: Mapping Regulatory Variants in the Alzheimer's Disease Candidate Gene ABCA7 Alzheimer's & Dementia. 12: P855-P855. DOI: 10.1016/J.Jalz.2016.06.1751 |
0.793 |
|
| 2016 |
Nho K, Kim S, Horgousluoglu E, Risacher SL, Apostolova LG, Lin K, Keohane A, Lunnon K, Hodges A, Allen M, Wang X, Burgess JD, Ertekin-Taner N, Petersen RC, Soares H, et al. P3-087: Gene Expression of ABCA7
Dysregulated in Peripheral Blood is Associated With Decreased Metabolic Activity in Hippocampus Alzheimer's & Dementia. 12: P851-P853. DOI: 10.1016/J.Jalz.2016.06.1746 |
0.54 |
|
| 2016 |
Sevlever D, Younkin M, Ma L, Nobutaka S, Bisceglio G, Dickson DW, Ertekin-Taner N, Younkin SG. P2-125: Analysis of Wild Type and R47H Mutant TREM2 Expression in Alzheimer's Disease Brains Alzheimer's & Dementia. 12: P659-P659. DOI: 10.1016/J.Jalz.2016.06.1495 |
0.618 |
|
| 2016 |
Nsongo A, Carrasquillo MM, Wang X, Burgess JD, Nguyen T, Asmann YW, Younkin SG, Graff-Radford NR, Ertekin-Taner N. P2-079: Assessment of The Known and Candidate Alzheimer's Disease Genes in African-Americans Alzheimer's & Dementia. 12: P639-P639. DOI: 10.1016/J.Jalz.2016.06.1284 |
0.745 |
|
| 2016 |
Nho K, Kim S, Risacher SL, Apostolova LG, Lin K, Keohane A, Lunnon K, Hodges A, Allen M, Wang X, Burgess JD, Ertekin-Taner N, Petersen RC, Soares H, Singh P, et al. IC-P-074: Genome-Wide Meta-Analysis of Transcriptome Profiling Identifies Novel Dysregulated Genes Implicated in Alzheimer’s Disease Alzheimer's & Dementia. 12: P58-P60. DOI: 10.1016/J.Jalz.2016.06.104 |
0.591 |
|
| 2015 |
Allen M, Kachadoorian M, Carrasquillo MM, Karhade A, Manly L, Burgess JD, Wang C, Serie D, Wang X, Siuda J, Zou F, Chai HS, Younkin C, Crook J, Medway C, ... ... Ertekin-Taner N, et al. Late-onset Alzheimer disease risk variants mark brain regulatory loci. Neurology. Genetics. 1: e15. PMID 27066552 DOI: 10.1212/Nxg.0000000000000012 |
0.831 |
|
| 2015 |
Carrasquillo MM, Barber I, Lincoln SJ, Murray ME, Camsari GB, Khan QU, Nguyen T, Ma L, Bisceglio GD, Crook JE, Younkin SG, Dickson DW, Boeve BF, Graff-Radford NR, Morgan K, ... Ertekin-Taner N, et al. Evaluating pathogenic dementia variants in posterior cortical atrophy. Neurobiology of Aging. PMID 26507310 DOI: 10.1016/J.Neurobiolaging.2015.09.023 |
0.726 |
|
| 2015 |
Ghani M, Reitz C, Cheng R, Vardarajan BN, Jun G, Sato C, Naj A, Rajbhandary R, Wang LS, Valladares O, Lin CF, Larson EB, Graff-Radford NR, Evans D, De Jager PL, ... ... Ertekin-Taner N, et al. Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals. Jama Neurology. PMID 26366463 DOI: 10.1001/Jamaneurol.2015.1700 |
0.491 |
|
| 2015 |
Hohman TJ, Cooke-Bailey JN, Reitz C, Jun G, Naj A, Beecham GW, Liu Z, Carney RM, Vance JM, Cuccaro ML, Rajbhandary R, Vardarajan BN, Wang LS, Valladares O, Lin CF, ... ... Ertekin-Taner N, et al. Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26092349 DOI: 10.1016/J.Jalz.2015.02.012 |
0.521 |
|
| 2015 |
Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A, Baker M, Finch NC, Yoon H, Kim J, Fujioka S, McLean CA, Ghetti B, Spina S, Cantwell LB, ... ... Ertekin-Taner N, et al. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nature Communications. 6: 7247. PMID 26077951 DOI: 10.1038/Ncomms8247 |
0.573 |
|
| 2015 |
Jin SC, Carrasquillo MM, Benitez BA, Skorupa T, Carrell D, Patel D, Lincoln S, Krishnan S, Kachadoorian M, Reitz C, Mayeux R, Wingo TS, Lah JJ, Levey AI, Murrell J, ... ... Ertekin-Taner N, et al. TREM2 is associated with increased risk for Alzheimer's disease in African Americans. Molecular Neurodegeneration. 10: 19. PMID 25886450 DOI: 10.1186/S13024-015-0016-9 |
0.65 |
|
| 2015 |
Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Ertekin-Taner N, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157 |
0.65 |
|
| 2015 |
Carrasquillo MM, Crook JE, Pedraza O, Thomas CS, Pankratz VS, Allen M, Nguyen T, Malphrus KG, Ma L, Bisceglio GD, Roberts RO, Lucas JA, Smith GE, Ivnik RJ, Machulda MM, ... ... Ertekin-Taner N, et al. Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease. Neurobiology of Aging. 36: 60-7. PMID 25189118 DOI: 10.1016/J.Neurobiolaging.2014.07.042 |
0.751 |
|
| 2015 |
Ghani M, Reitz C, Cheng R, Vardarajan BN, Jun G, Sato C, Naj A, Rajbhandary R, Wang LS, Valladares O, Lin CF, Larson EB, Graff-Radford NR, Evans D, De Jager PL, ... ... Ertekin-Taner N, et al. Association of long runs of homozygosity with Alzheimer disease among African American individuals Jama Neurology. 72: 1313-1323. DOI: 10.1001/jamaneurol.2015.1700z |
0.342 |
|
| 2014 |
Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai HS, Younkin C, Crook JE, Pankratz VS, Carrasquillo MM, Krishnan S, Nguyen T, Ma L, Malphrus K, Lincoln S, Bisceglio G, ... ... Ertekin-Taner N, et al. Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels. Alzheimer's Research & Therapy. 6: 39. PMID 25324900 DOI: 10.1186/Alzrt268 |
0.795 |
|
| 2014 |
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Ertekin-Taner N, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491 |
0.744 |
|
| 2014 |
Logue MW, Schu M, Vardarajan BN, Farrell J, Bennett DA, Buxbaum JD, Byrd GS, Ertekin-Taner N, Evans D, Foroud T, Goate A, Graff-Radford NR, Kamboh MI, Kukull WA, Manly JJ, et al. Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 609-618.e11. PMID 25172201 DOI: 10.1016/J.Jalz.2014.06.010 |
0.514 |
|
| 2014 |
De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, Eaton ML, Keenan BT, Ernst J, McCabe C, Tang A, Raj T, Replogle J, Brodeur W, Gabriel S, ... ... Ertekin-Taner N, et al. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nature Neuroscience. 17: 1156-63. PMID 25129075 DOI: 10.1038/Nn.3786 |
0.639 |
|
| 2014 |
Gusareva ES, Carrasquillo MM, Bellenguez C, Cuyvers E, Colon S, Graff-Radford NR, Petersen RC, Dickson DW, Mahachie John JM, Bessonov K, Van Broeckhoven C, Harold D, Williams J, Amouyel P, ... ... Ertekin-Taner N, et al. Genome-wide association interaction analysis for Alzheimer's disease. Neurobiology of Aging. 35: 2436-43. PMID 24958192 DOI: 10.1016/J.Neurobiolaging.2014.05.014 |
0.684 |
|
| 2014 |
Carrasquillo MM, Khan Qu, Murray ME, Krishnan S, Aakre J, Pankratz VS, Nguyen T, Ma L, Bisceglio G, Petersen RC, Younkin SG, Dickson DW, Boeve BF, Graff-Radford NR, Ertekin-Taner N. Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD. Neurology. 82: 1455-62. PMID 24670887 DOI: 10.1212/Wnl.0000000000000335 |
0.761 |
|
| 2014 |
Medway CW, Abdul-Hay S, Mims T, Ma L, Bisceglio G, Zou F, Pankratz S, Sando SB, Aasly JO, Barcikowska M, Siuda J, Wszolek ZK, Ross OA, Carrasquillo M, Dickson DW, ... ... Ertekin-Taner N, et al. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease. Molecular Neurodegeneration. 9: 11. PMID 24607147 DOI: 10.1186/1750-1326-9-11 |
0.739 |
|
| 2014 |
Mukherjee S, Kim S, Ramanan VK, Gibbons LE, Nho K, Glymour MM, Ertekin-Taner N, Montine TJ, Saykin AJ, Crane PK. Gene-based GWAS and biological pathway analysis of the resilience of executive functioning. Brain Imaging and Behavior. 8: 110-8. PMID 24072271 DOI: 10.1007/S11682-013-9259-7 |
0.38 |
|
| 2014 |
Pedraza O, Allen M, Jennette K, Carrasquillo M, Crook J, Serie D, Pankratz VS, Palusak R, Nguyen T, Malphrus K, Ma L, Bisceglio G, Roberts RO, Lucas JA, Ivnik RJ, ... ... Ertekin-Taner N, et al. Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 205-13. PMID 23643458 DOI: 10.1016/J.Jalz.2013.01.016 |
0.733 |
|
| 2014 |
Medway CW, Abdul-Hay S, Mims T, Zou F, Ma L, Bisceglio G, Pankratz S, Sando S, Aasly J, Barcikowska M, Siuda J, Wszolek Z, Ross O, Carrasquillo MM, Dickson DW, ... ... Ertekin-Taner N, et al. P1-055: MULTIPLE ABCA7 MISSENSE VARIANTS MINED FROM THE EXOME VARIANT SERVER SHOW INDEPENDENT ASSOCIATION WITH INCREASED OR DECREASED RISK OF LATE-ONSET ALZHEIMER'S DISEASE (LOAD) Alzheimer's & Dementia. 10: P323-P323. DOI: 10.1016/J.Jalz.2014.05.291 |
0.762 |
|
| 2014 |
Carrasquillo MM, Allen M, Zou F, Chai HS, Younkin C, Crook J, Pancratz VS, Nair A, Middha S, Maharjan S, Nguyen T, Ma L, Lincoln S, Malphrus K, Bisceglio G, ... ... Ertekin-Taner N, et al. P3-022: TRANSCRIPTIONAL REGULATION AT THE TREM
GENE CLUSTER IN AD BRAINS Alzheimer's & Dementia. 10: P635-P635. DOI: 10.1016/J.Jalz.2014.05.1109 |
0.749 |
|
| 2014 |
Kachadoorian M, Allen M, Lincoln S, Karhade A, Manly L, Zou F, Chai HS, Younkin C, Crook J, Pancratz VS, Carrasquillo MM, Nair A, Middha S, Maharjan S, Nguyen T, ... ... Ertekin-Taner N, et al. O4-04-06: TRANSCRIPTIONAL REGULATION OF GENES AT THE ALZHEIMER'S DISEASE RISK LOCI Alzheimer's & Dementia. 10: P258-P258. DOI: 10.1016/J.Jalz.2014.04.407 |
0.783 |
|
| 2014 |
Allen M, Serie D, Sun Z, Baheti S, Walsh M, Zou F, Chai HS, Younkin C, Siuda J, Burgess J, Crook J, Pancratz VS, Carrasquillo MM, Nair A, Middha S, ... ... Ertekin-Taner N, et al. O3-04-06: GENE EXPRESSION PROFILING AND DNA METHYLATION IN ALZHEIMER'S DISEASE BRAINS Alzheimer's & Dementia. 10: P216-P216. DOI: 10.1016/J.Jalz.2014.04.291 |
0.765 |
|
| 2014 |
Ertekin-Taner N, Wang C, Carrasquillo MM, Allen M, Younkin C, Serie D, Wang X, Pancratz VS, Nguyen T, Ma L, Malphrus K, Lincoln S, Petersen RC, Graff-Radford NR, Dickson DW, et al. O3-04-01: NEXT-GENERATION RNA SEQUENCING IN ALZHEIMER'S DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY Alzheimer's & Dementia. 10: P214-P215. DOI: 10.1016/J.Jalz.2014.04.286 |
0.752 |
|
| 2013 |
Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Josephs KA, Knopman DS, White CL, Caselli R, ... ... Ertekin-Taner N, et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Molecular Neurodegeneration. 8: 19. PMID 23800361 DOI: 10.1186/1750-1326-8-19 |
0.675 |
|
| 2013 |
Ertekin-Taner N. Alzheimer disease: the quest for Alzheimer disease genes--focus on CSF tau. Nature Reviews. Neurology. 9: 368-70. PMID 23752907 DOI: 10.1038/Nrneurol.2013.117 |
0.562 |
|
| 2013 |
Lincoln S, Allen M, Cox CL, Walker LP, Malphrus K, Qiu Y, Nguyen T, Rowley C, Kouri N, Crook J, Pankratz VS, Younkin S, Younkin L, Carrasquillo M, Zou F, ... ... Ertekin-Taner N, et al. LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD). Plos One. 8: e64164. PMID 23750206 DOI: 10.1371/Journal.Pone.0064164 |
0.788 |
|
| 2013 |
Nicholson AM, Finch NA, Wojtas A, Baker MC, Perkerson RB, Castanedes-Casey M, Rousseau L, Benussi L, Binetti G, Ghidoni R, Hsiung GY, Mackenzie IR, Finger E, Boeve BF, Ertekin-Taner N, et al. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia. Journal of Neurochemistry. 126: 781-91. PMID 23742080 DOI: 10.1111/Jnc.12329 |
0.41 |
|
| 2013 |
Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, Valladares O, Lin CF, Larson EB, Graff-Radford NR, Evans D, De Jager PL, Crane PK, Buxbaum JD, Murrell JR, ... ... Ertekin-Taner N, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. Jama. 309: 1483-92. PMID 23571587 DOI: 10.1001/Jama.2013.2973 |
0.54 |
|
| 2013 |
Ertekin-Taner N, De Jager PL, Yu L, Bennett DA. Alternative Approaches in Gene Discovery and Characterization in Alzheimer's Disease. Current Genetic Medicine Reports. 1: 39-51. PMID 23482655 DOI: 10.1007/S40142-013-0007-5 |
0.522 |
|
| 2013 |
Klein CJ, Bird T, Ertekin-Taner N, Lincoln S, Hjorth R, Wu Y, Kwok J, Mer G, Dyck PJ, Nicholson GA. DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing loss. Neurology. 80: 824-8. PMID 23365052 DOI: 10.1212/Wnl.0B013E318284076D |
0.314 |
|
| 2013 |
Carrasquillo M, Crook J, Pedraza O, Pankratz V, Allen M, Nguyen T, Malphrus K, Ma L, Bisceglio G, Roberts R, Lucas J, Ivnik R, Machulda M, Graff-Radford N, Petersen R, ... ... Ertekin-Taner N, et al. P4-004: Association study of late-onset Alzheimer's disease risk variants and memory decline Alzheimer's & Dementia. 9: P706-P706. DOI: 10.1016/J.Jalz.2013.05.1392 |
0.793 |
|
| 2013 |
Carrasquillo M, Khan QuA, Murray M, Krishnan S, Nguyen T, Ma L, Bisceglio G, Dickson D, Younkin S, Boeve B, Graff-Radford N, Ertekin-Taner N. Association study of late-onset Alzheimer's disease risk variants and risk for posterior cortical atrophy Alzheimers & Dementia. 9: 553. DOI: 10.1016/J.Jalz.2013.05.1078 |
0.742 |
|
| 2013 |
Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai HS, Younkin C, Crook J, Pankratz V, Carrasquillo M, Krishnan S, Nguyen T, Ma L, Malphrus K, Lincoln S, Bisceglio G, ... ... Ertekin-Taner N, et al. O5-01-05: Haplotypes at the MAPT locus associate with risk for LOAD and brain gene expression Alzheimer's & Dementia. 9: P829-P829. DOI: 10.1016/J.Jalz.2013.04.473 |
0.75 |
|
| 2013 |
Carrasquillo MM, Allen M, Ertekin-Taner N. Other genes implicated in Alzheimer's disease Genetic Variants in Alzheimer's Disease. 209-230. DOI: 10.1007/978-1-4614-7309-1_12 |
0.738 |
|
| 2012 |
Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN, Nair AA, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus KG, Palusak R, ... ... Ertekin-Taner N, et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 79: 221-8. PMID 22722634 DOI: 10.1212/Wnl.0B013E3182605801 |
0.799 |
|
| 2012 |
Mukherjee S, Kim S, Gibbons LE, Nho K, Risacher SL, Glymour MM, Habeck C, Lee GJ, Mormino E, Ertekin-Taner N, Montine TJ, Decarli C, Saykin AJ, Crane PK. Genetic architecture of resilience of executive functioning. Brain Imaging and Behavior. 6: 621-33. PMID 22711244 DOI: 10.1007/S11682-012-9184-1 |
0.475 |
|
| 2012 |
Zou F, Chai HS, Younkin CS, Allen M, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN, Nair AA, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus KG, Palusak R, ... ... Ertekin-Taner N, et al. Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. Plos Genetics. 8: e1002707. PMID 22685416 DOI: 10.1371/Journal.Pgen.1002707 |
0.821 |
|
| 2012 |
Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS, Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, ... ... Ertekin-Taner N, et al. Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Molecular Neurodegeneration. 7: 13. PMID 22494505 DOI: 10.1186/1750-1326-7-13 |
0.808 |
|
| 2012 |
Allen M, Cox C, Belbin O, Ma L, Bisceglio GD, Wilcox SL, Howell CC, Hunter TA, Culley O, Walker LP, Carrasquillo MM, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG, ... Ertekin-Taner N, et al. Association and heterogeneity at the GAPDH locus in Alzheimer's disease. Neurobiology of Aging. 33: 203.e25-33. PMID 20864222 DOI: 10.1016/J.Neurobiolaging.2010.08.002 |
0.76 |
|
| 2012 |
Ertekin-Taner N, Zou F, Chai HS, Younkin C, Crook J, Pankratz V, Allen M, Carrasquillo M, Rowley C, Nair A, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus K, et al. Identification of human disease-associated variants in a brain expression genome-wide association study (eGWAS) Alzheimers & Dementia. 8: 178. DOI: 10.1016/J.Jalz.2012.05.480 |
0.768 |
|
| 2012 |
Reitz C, Manly J, Hall KS, Evans D, Bennett D, Buxbaum J, Ertekin-Taner N, Fallin D, Kamboh I, Foroud T, Goate A, Farrer L, Pericak-Vance M, Haines J, Mayeux R, et al. CTNNA3, CAPRIN2 and SPG20 are significantly associated with Alzheimer's disease in preliminary analyses of a genome-wide association study in African-Americans Alzheimers & Dementia. 8: 100. DOI: 10.1016/J.Jalz.2012.05.251 |
0.482 |
|
| 2012 |
Ertekin-Taner N, Allen M, Murray M, Crook J, Serie D, Zou F, Chai HS, Younkin C, Pankratz V, Carrasquillo M, Rowley C, Nair A, Middha S, Maharjan S, Nguyen T, et al. O5-03-03: Genetic association of progressive supranuclear palsy (PSP) risk loci variants with brain gene expression and neuropathology endophenotypes Alzheimer's & Dementia. 8: P735-P735. DOI: 10.1016/J.Jalz.2012.05.1983 |
0.762 |
|
| 2012 |
Jager PD, Srivastava G, Eaton M, Chibnik L, Keenan B, Zou F, Song H, Younkin C, Younkin S, Ertekin-Taner N, Bernstein B, Meissner A, Kellis M, Bennett D. Genome-wide exploration of DNA methylation in the aging brain and its relation to Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.1829 |
0.592 |
|
| 2012 |
Bisceglio G, Graff-Radford N, Talisha H, Ertekin-Taner N, Younkin S, Carrasquillo M. P4-123: The genetics of cognitively healthy aging Alzheimer's & Dementia. 8: P674-P675. DOI: 10.1016/J.Jalz.2012.05.1826 |
0.638 |
|
| 2012 |
Allen M, Pedraza O, Nguyen T, Bisceglio G, Flingai S, Miles R, Hirpa M, Ma L, Malphrus K, Petersen R, Graff-Radford N, Younkin S, Ertekin-Taner N. P3-257: Investigation of established Alzheimer's disease-risk SNPs for association with Alzheimer's disease in an African-American case control series Alzheimer's & Dementia. 8: P549-P550. DOI: 10.1016/J.Jalz.2012.05.1480 |
0.755 |
|
| 2012 |
Allen M, Zou F, Chai HS, Younkin C, Crook J, Pankratz V, Carrasquillo M, Rowley C, Nair A, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus K, Palusak R, ... ... Ertekin-Taner N, et al. Genetic association of variants with late-onset Alzheimer's disease risk and brain gene expression Alzheimers & Dementia. 8: 451. DOI: 10.1016/J.Jalz.2012.05.1202 |
0.812 |
|
| 2011 |
Ertekin-Taner N. Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer's disease. Molecular Neurodegeneration. 6: 31. PMID 21569597 DOI: 10.1186/1750-1326-6-31 |
0.471 |
|
| 2011 |
Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, ... ... Ertekin-Taner N, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics. 43: 436-41. PMID 21460841 DOI: 10.1038/Ng.801 |
0.689 |
|
| 2011 |
Burgess JD, Pedraza O, Graff-Radford NR, Hirpa M, Zou F, Miles R, Nguyen T, Li M, Lucas JA, Ivnik RJ, Crook J, Pankratz VS, Dickson DW, Petersen RC, Younkin SG, ... Ertekin-Taner N, et al. Association of common KIBRA variants with episodic memory and AD risk. Neurobiology of Aging. 32: 557.e1-9. PMID 21185624 DOI: 10.1016/J.Neurobiolaging.2010.11.004 |
0.64 |
|
| 2011 |
Pedraza O, Allen M, Crook J, Ivnik R, Smith G, Knopman D, Pankratz V, Graff-Radford N, Roberts R, Petersen R, Younkin S, Ertekin-Taner N. P1-458: Differential association of memory endophenotypes to APOE alleles Alzheimer's & Dementia. 7: S260-S260. DOI: 10.1016/J.Jalz.2011.05.740 |
0.636 |
|
| 2011 |
Pedraza O, Allen M, Jennette K, Crook J, Carrasquillo M, Palusak R, Nguyen T, Malphrus K, Ivnik R, Smith GE, Knopman D, Pankratz S, Graff-Radford N, Roberts R, Petersen R, ... ... Ertekin-Taner N, et al. P1-252: Evaluation of Cognitive Endophenotypes for Association with CLU, CR1 and PICALM LOAD Risk Genes Alzheimer's & Dementia. 7: S191-S192. DOI: 10.1016/J.Jalz.2011.05.532 |
0.734 |
|
| 2011 |
Ertekin-Taner N, Zou F, Chai H, Younkin C, Crook J, Pankratz S, Allen M, Carrasquillo M, Rowley C, Pedraza O, Ansari M, Hayward C, Rudan I, Campbell H, Polasek O, et al. Genome-Wide Association Study of Brain Gene Expression Levels (eGWAS) Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.509 |
0.744 |
|
| 2011 |
Allen M, Zou F, Chai HS, Younkin C, Crook J, Pankratz S, Carrasquillo M, Rowley C, Nair A, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus K, Palusak R, ... ... Ertekin-Taner N, et al. O3-01-08: Evaluation of known Alzheimer's genes for SNPs that influence their brain expression (eSNPs) Alzheimer's & Dementia. 7: S498-S498. DOI: 10.1016/J.Jalz.2011.05.2392 |
0.767 |
|
| 2010 |
Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P, et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of Neurology. 67: 1473-84. PMID 20697030 DOI: 10.1001/Archneurol.2010.201 |
0.465 |
|
| 2010 |
Ertekin-Taner N. Genetics of Alzheimer disease in the pre- and post-GWAS era. Alzheimer's Research & Therapy. 2: 3. PMID 20236449 DOI: 10.1186/Alzrt26 |
0.497 |
|
| 2010 |
Zou F, Carrasquillo MM, Pankratz VS, Belbin O, Morgan K, Allen M, Wilcox SL, Ma L, Walker LP, Kouri N, Burgess JD, Younkin LH, Younkin SG, Younkin CS, Bisceglio GD, ... ... Ertekin-Taner N, et al. Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease. Neurology. 74: 480-6. PMID 20142614 DOI: 10.1212/Wnl.0B013E3181D07654 |
0.775 |
|
| 2010 |
Carrasquillo MM, Belbin O, Zou F, Allen M, Ertekin-Taner N, Ansari M, Wilcox SL, Kashino MR, Ma L, Younkin LH, Younkin SG, Younkin CS, Dincman TA, Howard ME, Howell CC, et al. Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease. Plos One. 5: e8764. PMID 20098734 DOI: 10.1371/Journal.Pone.0008764 |
0.792 |
|
| 2010 |
DelleDonne A, Miles RJ, Dickson DW, Abdul-Hay SO, Ertekin-Taner N, Leissring MA. P1-292: Correlation between insulin-degrading enzyme levels and neuropathology in control versus Alzheimer brains with and without cerebral amyloid angiopathy Alzheimer's & Dementia. 6: S258-S258. DOI: 10.1016/J.Jalz.2010.05.844 |
0.371 |
|
| 2010 |
Palusak R, Zou F, Miles R, Carrasquillo M, Ma L, Nguyen T, Dickson D, Petersen RC, Graff-Radford NR, Younkin SG, Ertekin-Taner N. P1-102: Investigating cis-SNP/mRNA level associations of candidate Alzheimer genes in different brain regions of patients and controls Alzheimer's & Dementia. 6: S204-S204. DOI: 10.1016/J.Jalz.2010.05.651 |
0.716 |
|
| 2010 |
Ertekin-Taner N, Burgess J, Hirpa M, Nguyen T, Li M, Fanggeng Z, Younkin SG, Crook JE, Pankratz V, Petersen RC, Graff-Radford NR, Pedraza O. P1-098: Association of common KIBRA variants with episodic memory and Alzheimer risk Alzheimer's & Dementia. 6: S203-S203. DOI: 10.1016/J.Jalz.2010.05.646 |
0.58 |
|
| 2010 |
Miles RJ, DelleDonne A, Zou F, Murray M, Ma L, Nguyen T, Bisceglio G, Dickson DW, Younkin S, Leissring MA, Ertekin-Taner N. P1-095: Characterization of brain region- and disease-specific IDE expression in Alzheimer patients and controls Alzheimer's & Dementia. 6: S202-S202. DOI: 10.1016/J.Jalz.2010.05.643 |
0.601 |
|
| 2010 |
Allen M, Cox C, Belbin O, Ma L, Bisceglio GD, Wilcox SL, Howell CC, Hunter TA, Culley O, Walker LP, Carrasquillo MM, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG, ... Ertekin-Taner N, et al. P1-058: Association of glyceraldehyde-3-phosphate dehydrogenase locus variant with late-onset Alzheimer's disease Alzheimer's & Dementia. 6: S190-S190. DOI: 10.1016/J.Jalz.2010.05.606 |
0.809 |
|
| 2010 |
Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, Younkin CS, Younkin LH, Bisceglio GD, Ertekin-Taner N, Crook JE, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG. Genetic variation in PCDH11X is associated with susceptibility to late onset alzheimer's disease Hirosaki Medical Journal. 61: S125-S134. |
0.726 |
|
| 2009 |
Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, Younkin SG, Younkin CS, Younkin LH, Bisceglio GD, Ertekin-Taner N, Crook JE, Dickson DW, Petersen RC, Graff-Radford NR, et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Nature Genetics. 41: 192-8. PMID 19136949 DOI: 10.1016/J.Jalz.2009.05.518 |
0.708 |
|
| 2009 |
Leissring MA, Reinstatler L, Sahara T, Sevlever D, Roman R, Ji Z, Li L, Lu Q, Säftig P, Levites Y, Golde TE, Burgess J, Ertekin-Taner N, Eckman EA. O4-03-07: Cathepsin D knockout mice harbor large and highly selective increases in cerebral Aß42 and tau: Implications for Alzheimer's disease pathogenesis Alzheimer's & Dementia. 5: P155-P156. DOI: 10.1016/J.Jalz.2009.05.537 |
0.406 |
|
| 2009 |
Belbin O, Carrasquillo M, Zou F, Allen M, Ertekin-Taner N, Brown K, Passmore P, Craig D, McGuinness B, Todd S, Kehoe PG, Mann DM, Smith AD, Beaumont H, Warden D, et al. P4-130: Concordant association of functional IDE variant with IDE mRNA, Aß, and Alzheimer's disease Alzheimer's & Dementia. 5: P469-P470. DOI: 10.1016/J.Jalz.2009.04.798 |
0.795 |
|
| 2009 |
Burgess J, Leissring MA, Ma L, Younkin LH, Reinstatler L, Crook JE, Pankratz VS, Dickson DW, Peterson RC, Graff-Radford NR, Younkin SG, Ertekin-Taner N. P4-128: Association of a missense cathepsin D (CTSD) SNP with risk of Alzheimer's disease Alzheimer's & Dementia. 5: P469-P469. DOI: 10.1016/J.Jalz.2009.04.796 |
0.649 |
|
| 2008 |
Ertekin-Taner N, Younkin LH, Yager DM, Parfitt F, Baker MC, Asthana S, Hutton ML, Younkin SG, Graff-Radford NR. Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families. Neurology. 70: 596-606. PMID 17914065 DOI: 10.1212/01.Wnl.0000278386.00035.21 |
0.592 |
|
| 2008 |
Younkin SG, Carrasquillo M, Younkin S, Zou F, Walker LP, Wilcox S, Younkin C, Pishotta FT, Ma L, Bisceglio G, Kouri N, Pankratz VS, Cunningham JM, Petersen RC, Graff-Radford NR, ... ... Ertekin-Taner N, et al. P3-275: Genome-wide association study for Braak neurofibrillary tangle (NFT) staging Alzheimer's & Dementia. 4: T602-T603. DOI: 10.1016/J.Jalz.2008.05.1843 |
0.682 |
|
| 2008 |
Walker L, Allen M, Cox C, Younkin S, Younkin L, Carrasquillo M, Zou F, Ma L, Kouri N, Pankratz VS, Dickson D, Boeve B, Petersen RC, Graff-Radford NR, Younkin SG, ... Ertekin-Taner N, et al. P3-271: Association of candidate gene susceptibility alleles on chromosome 10 with Alzheimer's disease risk and endophenotypes Alzheimer's & Dementia. 4: T601-T601. DOI: 10.1016/J.Jalz.2008.05.1839 |
0.798 |
|
| 2008 |
Ertekin-Taner N, Zou F, Carrasquillo M, Younkin S, Ma L, Walker LP, Wilcox S, Bisceglio G, Kouri N, Pankratz VS, Cunningham JM, Dickson D, Petersen RC, Graff-Radford NR, Younkin SG. P3-216: Identification of CIS
variants associating with expression levels of 12 late-onset Alzheimer's disease (LOAD) candidate genes in a Genome-Wide Association Study (GWAS) Alzheimer's & Dementia. 4: T584-T584. DOI: 10.1016/J.Jalz.2008.05.1783 |
0.761 |
|
| 2008 |
Carrasquillo MM, Younkin SG, Zou F, Ma L, Wilcox SL, Walker LP, Bisceglio G, Ertekin-Taner N, Pankratz VS, Cunningham JM, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG. P3-208: Genetic variation in PCDH11X associates with Alzheimer's disease in a two-stage GWAS study Alzheimer's & Dementia. 4: T581-T582. DOI: 10.1016/J.Jalz.2008.05.1775 |
0.745 |
|
| 2007 |
Ertekin-Taner N. Genetics of Alzheimer's disease: a centennial review. Neurologic Clinics. 25: 611-67, v. PMID 17659183 DOI: 10.1016/J.Ncl.2007.03.009 |
0.475 |
|
| 2006 |
Goldstein ED, Stephens A, Graff-Radford NR, Carrasquillo MM, Boeve BF, Tatum WO, Ertekin-Taner N, Feyissa AM. P2-290: ELECTROENCEPHALOGRAM FINDINGS IN PATIENTS WITH POSTERIOR CORTICAL ATROPHY Alzheimer's & Dementia. 14: P791-P792. DOI: 10.1016/J.Jalz.2018.06.979 |
0.541 |
|
| 2006 |
Hanna Al-Shaikh FS, Graff-Radford NR, Liesinger AM, Ertekin-Taner N, Ferman TJ, Ross OA, Pedraza O, Duara R, Dickson DW, Murray ME. P1-492: SELECTIVE VULNERABILITY OF THE CHOLINERGIC SYSTEM IN ALZHEIMER'S DISEASE SUBTYPES Alzheimer's & Dementia. 14: P516-P517. DOI: 10.1016/J.Jalz.2018.06.502 |
0.476 |
|
| 2006 |
Reddy JS, Allen M, Wang X, Biernacka JM, Gregory JD, Toral SM, McDonnell SK, Sarangi V, Sinnwell JP, Asmann YW, Carrasquillo MM, Pottier CP, Ren Y, Younkin CS, Rademakers R, ... ... Ertekin-Taner N, et al. O3-06-02: POLYGENIC SCORE ANALYSIS OF EXONIC VARIANTS IN AN IMMUNE CO-REGULATORY NETWORK IDENTIFIES NOVEL PROTEIN-ALTERING VARIANTS THAT ASSOCIATE WITH ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1025-P1026. DOI: 10.1016/J.Jalz.2018.06.2801 |
0.775 |
|
| 2006 |
Funk CC, Richards MA, Shannon P, Donovan-Maiye R, Rappaport N, Robinson M, Allen M, Carrasquillo MM, Chakrabarty P, McFarland K, Jung SC, Rodriguez A, Ertekin-Taner N, Golde TE, Hood L, et al. O3-03-01: MECHANISTIC AND DIRECTIONAL TRANSCRIPTIONAL REGULATORY NETWORKS IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1014-P1015. DOI: 10.1016/J.Jalz.2018.06.2782 |
0.708 |
|
| 2006 |
Wang X, Allen M, Carrasquillo MM, Burgess JD, Li S, Asmann YW, Ertekin-Taner N. P4-049: IDENTIFICATION OF CELL-SPECIFIC DIFFERENTIALLY EXPRESSED GENES IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P1452-P1452. DOI: 10.1016/J.Jalz.2018.06.2451 |
0.751 |
|
| 2006 |
Santos OA, Duara R, Lucas JA, Greig-Custo MT, Liesinger AM, Hanna Al-Shaikh FS, Ross OA, Ertekin-Taner N, Pedraza O, Graff-Radford NR, Dickson DW, Murray ME. P3-458: CLINICOPATHOLOGIC DIFFERENCES WITHIN ALZHEIMER'S DISEASE CASES FROM THE FLORIDA AUTOPSIED MULTI-ETHNIC (FLAME) STUDY Alzheimer's & Dementia. 14: P1293-P1294. DOI: 10.1016/J.Jalz.2018.06.1822 |
0.465 |
|
| 2006 |
Duara R, Loewenstein DA, Lizarraga G, Adjouadi M, Barker WW, Greig-Custo MT, Penate A, Hanson K, Marsiske M, Burke SL, Ertekin-Taner N, Vaillancourt D, DeKosky S, de Santi S, Golde TE. P3-378: EFFECT OF AGE, GENDER, ETHNICITY, COGNITION AND APOE GENOTYPE ON AMYLOID LOAD AMONG NORMAL, MCI AND MILD DEMENTIA SUBJECTS USING [F-18] FLORBETABEN Alzheimer's & Dementia. 14: P1237-P1238. DOI: 10.1016/J.Jalz.2018.06.1740 |
0.53 |
|
| 2006 |
Conway OJ, Carrasquillo MM, Bredenberg JM, Reddy JS, Younkin CS, Allen M, Nguyen T, Lincoln SJ, Malphrus KG, Duara R, Greig Custo MT, Petersen RC, Dickson DW, Graff-Radford NR, Ertekin-Taner N. P1-160: ABI3 AND PLCG2 AS RISK FACTORS FOR ALZHEIMER'S DISEASE IN CAUCASIANS AND AFRICAN AMERICANS Alzheimer's & Dementia. 14: P339-P339. DOI: 10.1016/J.Jalz.2018.06.164 |
0.746 |
|
| 2006 |
Carrasquillo MM, Reddy JS, Allen M, Reyes DA, McDonnell SK, Graff-Radford J, Kosel ML, Gregory JD, Nguyen T, Lincoln SJ, Malphrus KG, Crook JE, Jack CR, Lowe VJ, Knopman DS, ... ... Ertekin-Taner N, et al. P3-132: GENOME-WIDE ASSOCIATION STUDY OF CEREBRAL MICROBLEEDS AND INFARCTION IDENTIFIES CANDIDATE GENES FOR VASCULAR RISK IN DEMENTIA Alzheimer's & Dementia. 14: P1118-P1118. DOI: 10.1016/J.Jalz.2018.06.1489 |
0.711 |
|
| 2006 |
Allen M, Bredenberg JM, Reddy JS, Sarangi V, Carrasquillo MM, Wang X, Lincoln SJ, Nguyen T, Malphrus KG, Dickson DW, Asmann YW, Ertekin-Taner N. P3-129: MAPPING FUNCTIONAL REGULATORY VARIANTS AT ALZHEIMER'S DISEASE RISK LOCI Alzheimer's & Dementia. 14: P1117-P1117. DOI: 10.1016/J.Jalz.2018.06.1486 |
0.749 |
|
| 2006 |
Ertekin-Taner N, Allen M, Younkin L, Carrasquillo M, Younkin S, Greene MH, Kashino M, Singhal S, Dincman T, Petersen R, Graff-Radford N, Younkin SG. P1-353: Associaton of VR22 and LRRTM3 variants with late onset Alzheimer's disease (LOAD) and amyloid beta levels Alzheimer's & Dementia. 2: S201-S201. DOI: 10.1016/J.Jalz.2006.05.731 |
0.779 |
|
| 2006 |
Carrasquillo MM, Younkin SG, Kashino MR, Wilcox SL, Dincman TA, Howard ME, Li M, Zou F, Ertekin-Taner N, Allen M, Stanton CM, Watson CM, Younkin LH, Petersen RC, Graff-Radford N, et al. P1-310: Late onset Alzheimer's disease (LOAD) susceptibility alleles in the insulin-degrading-enzyme gene (IDE
) and other Aβ-degrading enzymes Alzheimer's & Dementia. 2: S187-S187. DOI: 10.1016/J.Jalz.2006.05.688 |
0.767 |
|
| 2005 |
Ertekin-Taner N, Ronald J, Feuk L, Prince J, Tucker M, Younkin L, Hella M, Jain S, Hackett A, Scanlin L, Kelly J, Kihiko-Ehman M, Neltner M, Hersh L, Kindy M, et al. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Human Molecular Genetics. 14: 447-60. PMID 15615772 DOI: 10.1093/Hmg/Ddi041 |
0.608 |
|
| 2004 |
Ertekin-Taner N, Allen M, Fadale D, Scanlin L, Younkin L, Petersen RC, Graff-Radford N, Younkin SG. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease. Human Mutation. 23: 334-42. PMID 15024728 DOI: 10.1002/Humu.20016 |
0.719 |
|
| 2004 |
Ertekin-Taner N, Ronald J, Allen M, Prince JA, Feuk L, Fadale D, Scanlin L, Asahara H, Younkin L, Hella M, Jain S, Gnida E, Stanton C, Younkin S, Ohyagi Y, et al. P4-095 Analysis of Alzheimer's disease candidate genes on chromosome 10 Neurobiology of Aging. 25: S501. DOI: 10.1016/S0197-4580(04)81653-1 |
0.714 |
|
| 2003 |
Whitaker C, Eckman C, Almeida C, Feinstein D, Atwood C, Eckman E, Crutcher K, Hersh L, Leissring M, LaVoie M, Ertekin-Taner N, Shapiro P, Takahashi R, Yamin R, Mansourian S, et al. Live discussion: Amyloid-β degradation: The forgotten half of Alzheimer's disease Journal of Alzheimer's Disease. 5: 491-497. PMID 14765518 |
0.317 |
|
| 2003 |
Ertekin-Taner N, Ronald J, Asahara H, Younkin L, Hella M, Jain S, Gnida E, Younkin S, Fadale D, Ohyagi Y, Singleton A, Scanlin L, de Andrade M, Petersen R, Graff-Radford N, et al. Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Human Molecular Genetics. 12: 3133-43. PMID 14559775 DOI: 10.1093/Hmg/Ddg343 |
0.6 |
|
| 2001 |
Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Adamson J, Schaid DJ, Blangero J, Hutton M, Younkin SG. Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees. Genetic Epidemiology. 21: 19-30. PMID 11443731 DOI: 10.1002/Gepi.1015 |
0.571 |
|
| 2000 |
Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin SG. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science (New York, N.Y.). 290: 2303-4. PMID 11125143 DOI: 10.1126/Science.290.5500.2303 |
0.59 |
|
| Show low-probability matches. |